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A b str a c t
This work describes the successful design, fabrication and implementation of 
a generic, optimised immunosensor. The first stage of the work was the es­
tablishment of the techniques required to develop an effective immunosensor, in 
particular, antibody immobilisation strategies, patterning methods and excita­
tion, detection and analysis systems. Once developed, these techniques were 
integrated and employed, in conjunction with a planar glass substrate, to obtain 
dose response curves for BSA/antiBSA antibody assays.
In parallel work, theoretical predictions relating to fluorescence emission were 
verified. It was shown that redirection of surface-confined fluorescence results in 
the enhancement of the fluorescence capture efficiency, and also that it is possible 
to discriminate between fluorescence originating at the surface and fluorescence 
originating from the bulk solution above the surface. These results have important 
implications for the design of fluorescence-based optical sensor platforms and were 
used in the design and fabrication of structured polymer biochips with enhanced 
fluorescence capture efficiency.
The final stage of the work presented here was the incorporation of the struc­
tured platforms with the immunosensmg systems established previously, in order 
to produce an optimised, generic, optical immunosensor. The replacement of 
the planar glass substrate with the enhanced polymer platform necessitated the 
adaptation of several of the systems. In particular, various antibody to polymer 
immobilisation strategies were investigated, with the optimum used to perform 
a full BSA/antiBSA antibody assay. A minimum detectable signal considerably 
lower than that of the planar immunosensor was achieved, thus validating the 
optimisations. The ability of this enhanced immunosensor to detect significantly 
lower levels of fluorescence has important implications for sensing applications 
where analytes are toxic in low concentrations or are only available in small quan­
tities, with these situations occurring in a wide range of areas including health 
care, food safety and early-warning biological warfare agent detection.
Chapter 1
Introduction
1.1 In tro d u ctio n :
From  Im m u n o lo g y  to  Im m u n o sen so rs
Immunisation, as a preventative measure against disease, was first practised over 
2500 years ago, with the Chinese inoculating healthy people with extracts from the 
pustules of those suffering from smallpox [1], However, it wasn’t until 1718 that 
this practice was first carried out in Europe and it was several years later before 
it was introduced in America [1]. Even at this stage, the practice remained purely 
empirical as the scientific community lacked fundamental knowledge of biological 
systems.
It was almost a century later, in the 1870’s, before immunology, the field of 
science concerned with the immune system, was founded. This was led by the 
work of Louis Pasteur and Elia Metchnikoff. Pasteur demonstrated the existence 
of microorganisms and applied systematic immunisation to chickens and cows [2]. 
Metchnikoff, Pasteur’s successor at the Pasteur Institute, Paris, is often referred 
to as the father of immunology due to his discovery that particular cells, which 
he termed phagocytes, destroy foreign bodies, such as bacteria [3].
The body of immunological knowledge did not increase significantly until the 
twentieth century, when immunology began to contribute in a very real manner to 
modern medicine. A  prime example of this was the discovery of blood groups by 
Karl Lansteiner, which directly led to the reduction of the major risks associated 
with blood transfusion incompatibility. Lansteiner was also part of the scientific
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community that, in the 1930s, began to isolate, purify and identify antibodies 
as an integral part of a body’s immune system. Furthermore, he demonstrated 
that these antibodies were capable of discriminating between small differences 
in molecular structure. His work showed that antibody recognition of molecules 
involved the shape, composition and spatial arrangement of the molecules’ func­
tional groups [4]. Through the 1940’s, 50’s and 60’s, a detailed picture of antibody 
recognition and antigen binding (an antigen being the molecule recognised by the 
antibody) was built by Pauling, Pressman, Kabat and others [5-7]. It was clear 
that the antibody/antigen binding mechanism was extremely selective, marking 
them as highly attractive sensing agents. Therefore, in the 1970’s, research into 
the use of antibodies to detect and quantify antigens (an area referred to as im­
munoassays) expanded rapidly [8]. This ultimately resulted in the widespread 
employment of immunoassays in current-day clinical laboratories [9].
Immunosensors refer to devices in which antibodies or antigens are coupled 
to a signal transducer that detects the binding of the two molecules. Combined 
with the volume of immunoassay research being carried out, the publication of 
a paper by Nylander et al. in 1982 led the way for the first major commercial 
immunosensor: the Pharmacia BIACore SPR-based biosensor system [10]. This 
system was launched in 1990 and remains one of just a small number of commer­
cially successful immunosensors. The potential benefits of immunosensors, for 
example in rapid point-of-care diagnosis, certainly make them worthy of develop­
ment. However, immunosensor research is still quite a new area, as is apparent 
from the low, and only recent increase in, number of publications from the area 
(see Figure 1.1) [11,12].
Consequently, the small number of commercialised immunosensors is not due 
to insufficient investment but partially due to the fact that immunosensor research 
is still quite a new area, with several challenges to overcome [13]. With the 
exception of home pregnancy tests (which are “yes/no” type sensors and so do not 
supply quantitative data on antigen concentrations), low cost, generic, effective 
immunosensors are not yet routinely available.
The primary aim of the work presented in this thesis was to develop an im­
munosensor fulfilling these requirements. In order to achieve this aim it was 
necessary to initially establish the techniques and systems required to develop 
an imunosensor. These included antibody immobilisation strategies, patterning
2
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Year
Figure 1.1: Histogram illustrating the number of publications containing the con­
cept "immunosensor". Results obtained using CAPLUS and MEDLINE databases.
methods and excitation and detection systems. Parallel work, involving the anal­
ysis of fluorescence emission, led to the design and fabrication of an optimised 
sensor platform. The subsequent incorporation of this platform into the im­
munosensor system resulted in the realisation of a low-cost, generic immunosensor 
with improved sensitivity.
1.2 C u rren t S ta te  o f  T h e  A rt
As the quantity of research focused on immunosensors is rapidly increasing, it 
is not possible to include references to all techniques currently being developed. 
Therefore, this section serves, not as a comprehensive review of the area, but to 
illustrate the variety of immunosensors currently being developed, giving exam­
ples of some of the major strategies being investigated and the advantages and 
limitations associated with each. As stated previously, though significant research 
is being currently carried out, generic, low-cost, effective immunosensors are not 
yet routinely available.
The immunosensor technologies being developed at present include electro­
chemical, mass-detection and heat-detection-based systems [13]. However, due 
to the numerous advantages that they offer over other techniques, optical im­
munosensors are currently the largest group of transducers [14]. Benefits include
3
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the non-invasive, non-destructive nature of these methods, their ability to mea­
sure hazardous materials and the rapid signal generation and read-out.
The majority of research in optical immunosensors is focused on either re­
fractive index-based or fluorescence-based detection methods. Therefore, expla­
nations and examples of the main optical immunosensor types are detailed below 
under these two category headings.
1.2.1 R efractive  In d ex-b ased  Im m u nosen sors
Surface plasmon resonance (SPR) is one of the most widely employed refractive 
index-based detection methods, with one of the leading commercial immunosen­
sors, the BIAcore™ system from Biacore (Upsala, Sweden) employing SPR-based 
detection and numerous research groups developing SPR-based systems [15-17]. 
A detailed explanation of SPR-based sensing is provided in Section 2.5.1. In sum­
mary, a beam of light is used to excite surface electrons (“plasmons” ) in a metal 
film that is coated onto a high refractive index material. This generates an evanes­
cent field, which propagates into a sample layer above the metal film. The field is 
highly sensitive to changes in refractive index, which occur when binding occurs 
in the sample layer. The attractiveness of this technology stems from the fact 
that labels are not required and the technology is extremely sensitive, as demon­
strated by Homola et al., who achieved a refractive index resolution of 4xl0-6  
RIU and applied this SPR-based immunosensor to the detection of staphylococcal 
enterotoxin B, achieving nanogram per milliliter limits of detection [18]. SPR is 
also attractive for its suitability for real-time and kinetic measurements, as shown 
by Campagnola et al. who employed an SPR-based immunosensor to analyse the 
binding activity of tumour antigens and cancer patient sera containing serum an­
tibodies [17]. Limitations of SPR-based sensors, as with the majority of refractive 
index-based sensors, include the fact that these sensors are sensitive to tempera­
ture and bulk refractive index changes. Also, they require high specificity of the 
binding layer to capture the target analyte and prevent non-specific binding to 
the surface, which could be recorded as a positive binding event.
Another immunosensor system being developed, which is similar in design to 
the SPR-based systems, is that of the resonant mirror optical immunosensor. It 
is this technology that is employed in the IAsys™  biosensor from Fisons Applied
4
1.2. Current State o f The Art H. M. McEvoy
Sensor Technology (Cambridge, UK). As with the SPR-based systems, an evanes­
cent field is used to detect small refractive index changes that occur when a target 
analyte binds to a capture antibody. The sensor is comprised of a prism block 
with a low refractive index layer above, followed by a high refractive index layer, 
which acts both as a waveguide and the sensor surface. Light is coupled into the 
prism block and at the resonant angle, passes through the low index layer and 
propagates within the high index layer. This results in an evanescent field in the 
sample above. The light emerging from the system is passed through a polariser, 
which ensures that only light propagated within the waveguiding layer reaches 
the detector. Refractive index changes in the sample affect the evanescent field, 
which in turn causes movement of the resonant angle. This systems lends itself 
well to rapid, real-time analysis, as demonstrated by Dimitriev et al., who em­
ployed a resonant mirror optical immunosensor to carry out analysis of antibody- 
antigen interactions, specifically the binding of bispecific antibodies with human 
IgG and horseradish peroxidase [19]. Hoare et al., monitoring the production of 
antibody fragments, have been able to provide concentration data within 10  s of 
sample addition [20]. However, as with the majority of refractive index-based 
immunosensors, the resonant mirror immunosensors are limited by the fact that 
the binding of small molecules results in only small signal changes. One method 
employed to overcome this problem is the use of the smaller molecule as the 
capture agent and the larger one as the target analyte.
Szekacs et al. employed this strategy with the use of a diffraction grating-based 
immunosensor to successfully detect the herbicide trifluralin in the concentration 
range of 2xl0- 7  to 3xl0_5ng/ml [21]. Diffraction grating-based immunosensors 
rely on the principle that if light is incident on the periodically structured surface 
of a diffraction grating, a series of waves directed away from the surface at different 
angles is produced. Typically, this type of immunosensor has been more complex 
to fabricate and optimise than other sensor types. However, developments in 
polymer processing by Whitesides et al. and others has resulted in the fabrication 
of polymer diffraction gratings, which renders these issues less important [22,23].
Interferometric immunosensors are another class of sensors that have devel­
oped rapidly due to advances made in other technologies. These sensors compare 
differences between two light beams; a sensing beam and a reference beam. When 
combined, they produce an interference pattern of light and dark fringes. A chem­
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ical or physical reaction occurring along one of the beams causes a change in the 
refractive index, which is detected by the evanescent field and results in a shift 
of the interference pattern. Planar waveguides are a common format for these 
sensors, due to their long interaction length. Fabrication and optimisation of 
these waveguides has been assisted by advances in the telecommunications and 
semiconductor industries, while fluidic design has been significantly improved due 
to MEMS research [24]. Brynda et al. demonstrated the real-time analysis capa- 
bilites of these sensors in their measurement of analytes in blood plasmas [25]. 
A major limitation of interferometric immunosensors is that they require exacting 
design in order to control the beam paths and limit errant signals.
1 .2 .2  F lu orescen ce-b ased  Im m unosensors
Extensive research is currently being carried out in the area of electrochemilumi- 
nescence (ECL)-based immunosensors. These immunosensors rely on the princi­
ple that particular species/molecules/chemicals at an electrode undergo electron 
transfer to form excited states that emit light. In the majority of ECL-based im­
munosensors, the target analyte is not itself ECL-active but ECL-active species 
are employed as labels. For example, Paek et al. detected Legionella with a limit 
of detection of 2 ng/ml using ruthenium as an ECL-active label [26]. One of the 
reasons for the popularity of ECL-based immunosensors is the attractiveness of 
the labels, which are sensitive, inexpensive, nonhazardous and linear over a wide 
range (six orders of magnitude) [24]. They do, however, also have drawbacks, 
such as the necessity of carrying out stringent cleaning of the electrode both 
prior to and after operation.
The largest and most promising class of fluorescence-based immunosensors 
is that employing fluorescent labels, known as fluorophores. This is due to the 
significant advantages that fluorophores display over other labels. These include 
ease of handling, high stability, spatial resolution, multianalyte detection, re- 
readability (due to the long shelf-life of fluorophores), sensitivity, rapid detection, 
simple excitation and detection instrumentation and low total system cost [27].
Fluorescence-based immunosensors typically measure changes in fluorescence 
lifetime, polarisation or intensity. The lifetime is a property of the fluorophore, 
which corresponds to the average time a fluorophore spends in an excited state,
6
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between the absorption of a photon and its emission as fluorescence. Yuan et 
al. have combined the emerging technology of nanoparticles with fluorescence 
lifetime measurements to detect the presence of a-fetoprotein in human serum 
samples, achieving limits of detection of less than lng/ml. Lifetime measurements 
are attractive due to their insensitivity to bleaching and excitation variations and 
also their facile calibration [24], However, is it often seen as a technique requir­
ing relatively expensive and complex instrumentation. Current developments in 
excitation and detection systems, such as the use of low-cost LED as described 
by Wilson et al., show that these issues are declining in importance [28].
In contrast to most lifetime-based immunosensors, flow immunosensors based 
on fluorescence intensity measurements have been successfully developed at low 
cost and demonstrated as effective portable sensors [29]. These sensors are based 
on displacement assays, whereby labelled antigens are displaced from immo­
bilised antibodies by target antigens. Intensity measurements of the fluorescently- 
labelled displaced antigens are correlated to the concentration of target antigen 
present in the sample. The assay takes place under a constant flow, which allows 
subsequent samples to be analysed without resetting the system.
The portability, simplicity and direct and rapid detection provided by flow 
immunosensors has led to their use in on-site, real-time analysis, as described 
by Wilkins et al. in their detection of Hantavirus in human and mice blood [301. 
Unfortunately, an intrinsic limitation exists in this technology, namely, the degra­
dation of signal due to the fact that the number of labelled antigens present in 
the immunosensor are reduced with each measurement, resulting in a reduction 
of assay response over time [31]. For this reason, it is imperative that calibration 
steps be included for each immunoassay.
Displacement assays have also been carried out using waveguide-based im­
munosensors. These immunosensors, however, are not restricted to this assay 
format and can also be used with other formats such as sandwich and competi­
tive assays (see Section 2.5.3 for explanations of these assay types). Waveguide 
immunosensors are based on the principle that light propagating within a waveg­
uide generates an evanescent field, which is used to excite fluorescently-labelled 
antigens or antibodies immobilised on the surface of the waveguide. Using the 
evanescent field introduces surface specificity to the immunosensor and thus, en­
sures that the system is less affected by turbidity, particulates or fluorophores
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within the bulk solution. These immunosensors often display rapid detection 
times, with Rowe-Taitt et al., for example, monitoring six biohazardous ana­
lytes in 20mins [32], The most common example of waveguide-based sensors 
are optical fibre-based sensors. Many examples exist in the literature of opti­
cal fibres employed as platforms for immunosensing, employing either evanescent 
field excitation or developed as probe-types systems [33-35]. However, optical 
fibres suffer from several disadvantages, such as lack of robustness and stringent 
coupling requirements, which make them problematic to employ outside of the 
lab as portable sensors. For these reasons, planar-based platforms formed the 
focus of this work. The geometry of the planar waveguide-based immunosen­
sor is inherently more robust than that of an optical fibre. Ligler et al. have 
also demonstrated the multianalyte capabilities of these planar immunosensors 
by patterning multiple capture antibodies along the length of the waveguides and 
simultaneously detecting multiple target antigens [36].
Due to the advantages displayed by planar waveguide immunosensors, the ini­
tial immunosensor presented in this thesis was based on this planar waveguide 
technique. Subsequently, an immunosensor based on a novel polymer sensor plat­
form was designed, which demonstrated increased performance over the planar 
version.
1 .3  T h e s is  S tru c tu re
Chapter 1 provides the introduction to this work, explaining the concept of im­
munosensors and providing an overview of the the current state of the art in this 
area. An outline of the thesis is presented and the objectives of the work are 
stated.
Chapters 2 and 3 provide background knowledge required to understand the 
working of the immunosensor presented here. The two fundamental elements of 
the sensor, namely the sensing mechanism and transduction are detailed in Chap­
ter 2 and Chapter 3 respectively. In Chapter 2, antibodies are introduced and 
antigen detection explained in detail. Their role in immunoassays is presented 
and the various immunoassay formats employable are described. In Chapter 3 the 
concept of fluorescence is explained and the different fluorescence excitation tech­
niques are presented. In particular, waveguiding and evanescent wave excitation
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are described in detail.
Chapter 4 details the development of a planar immunosensor, employing the 
theory described in Chapters 2 and 3. Each of the elements required for the 
formation of the immunosensor are described, including antibody immobilisation, 
patterning techniques and excitation and detection systems. Integrating each of 
these techniques and systems culminates in the attainment of a full dose response 
curve for BSA/antiBSA.
Chapter 5 details the experimental verification of two separate predictions of 
a new theory, developed by a colleague, describing the angular emission of fluores­
cent dipoles at a surface. The first prediction states that, due to the emission of 
the fluorescence in distinct angular ranges, redirection of the fluorescence should 
result in increased signal detection. The design and fabrication of a structured 
platform to test this prediction is presented and experimental verification of the 
prediction is provided. Experimental verification is also provided for the second 
prediction, which states that it is possible to discriminate between fluorescence 
originating from the surface and fluorescence originating from the bulk solution. 
In the final section of the chapter, the structured platform is investigated to de­
termine if the ability to discriminate between surface and bulk fluorescence is 
inherent in the design.
Chapter 6 details the optimisation of the planar immunosensor presented in 
Chapter 4. The main feature of the enhanced immunosensor is the substitution of 
the planar glass substrate with the structured polymer platform developed as a re­
sult of the work presented in Chapter 5. Replacement of the glass substrate with 
a polymer platform necessitated the use of a new antibody immobilisation strat­
egy. The investigation of several antibody to polymer immobilisation strategies 
is presented and a suitable strategy selected. The incorporation of the structured 
polymer substrate required the adaptation of each of the other techniques and sys­
tems developed in Chapter 4. These modifications to the patterning, excitation, 
detection and analysis systems are described and finally, results are presented 
from an immunoassay successfully carried out using the enhanced immunosensor.
Chapter 7 draws the conclusions of the work, namely that techniques for 
developing an effective immunosensor have been established and enhancement 
strategies were thoroughly investigated and implemented. The end result of the 
work is the successful design, fabrication and implementation of a generic, opti­
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mised immunosensor.
1 .4  T h e s is  O b je c tiv e s
• To establish the techniques required to develop an effective optical im- 
munosensor, in particular, antibody immobilisation strategies, patterning 
methods and excitation, detection and analysis systems.
• To verify theoretical predictions relating to fluorescence emission and use 
the results obtained in the design and fabrication of an enhanced platform 
for fluorescence detection.
• To develop a generic, optical immunosensor, with enhanced fluorescence 
detection capabilities.
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Chapter 2 
B iorecognition
2 .1  In tr o d u c tio n
As explained in Section 1.1, immunosensors employ antibodies as their sensing 
agents. This chapter will provide a thorough description of antibodies in terms of 
their function and structure and give reasons for their choice. The antibody bind­
ing mechanism will be detailed, with reference to binding site composition and 
the forces involved. Finally, the various immunoassay categories and formats 
commonly employed in immunosensing will be explained.
2 .2  P r o te in s
Antibodies are a subgroup of proteins, which, due to their high availability and 
specificity, are one of the major types of biomolecules employed in biosensors. 
Other commonly used biomolecules include nucleic acids such as deoxyribonucleic 
acid (DNA) or ribonucleic acid (RNA) [1-4]. The basic building blocks of pro­
teins are amino acids, which are molecules containing amine (NH2) and carboxyl 
(COOH) functional groups [5]. Their chemical structure is shown in Figure 2.1, 
where R represents a side chain. These side chains distinguish one amino acid 
from another and determine properties such as size, charge and hydrophobicity.
Amino acids link together to form long chains known as polypeptides. The 
name arises from the fact that each of the amino acids is joined via peptide bonds, 
which are the bonds formed between amine and carboxyl groups, as shown in
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Figure 2.1: Chemical structure of an amino acid. R represents a side chain, which 
defines the amino acid.
Figure 2.2. Every polypeptide begins with a free amine group and is called the 
N-terminus. The opposite end of the polypeptide has a free carboxyl group and 
is referred to as the C-terminus.
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Figure 2.2: Formation of an amino acid chain. Binding occurs via peptide bonds, 
which are highlighted in red.
Proteins are complex organic compounds, which are composed of one or more 
polypeptide chains [6]. The position and arrangement of the amino acids deter­
mines both the function and the three-dimensional folded structure of the protein.
Enzymes, cell receptors and antibodies are three of the most widely used 
protein-based molecules in biosensors [7-15]. Enzymes are large molecules pro­
duced by living cells in order to catalyse biochemical reactions. The enzymes 
themselves are not changed by the reactions that they catalyse. Enzymes are of­
ten chosen as sensing agents due to their high specificity with regards to the type 
of chemical reaction they catalyse and the substance upon which they act [16]. 
An example of a widely used enzyme is that of glucose oxidase, which is commonly 
employed in glucose sensing [17-19].
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Cell receptors are protein-based structures found in the plasma membrane of 
cells, which bind specifically with a range of organic molecules, including proteins 
and viruses [6]. There are several modes of operation for cell receptors. One of the 
most common occurs when the receptor spans the cell membrane. The binding to 
the receptor induces a conformational change that activates the internal portion 
of the cell receptor to initiate a chain reaction of chemical changes within the 
cell [6].
The third main type of protein used as biosensor sensing agents are antibodies, 
which were the sensing agents chosen for use in the biosensor presented here. 
There were two main reasons for this. Firstly, there is considerable experience in 
the area of antibody engineering here at the National Centre for Sensor Research, 
at Dublin City University [20-24] and secondly, the fact that antibodies can be 
generated against a large variety of antigens. This is important as the biosensor 
presented here is intended to be a generic sensor, capable of detecting a wide 
variety of analytes.
2 .3  A n tib o d ie s
2.3 .1  A n tib o d y  F un ction
Antibodies are an integral part of a body’s immune system. When a foreign 
molecule, such as a pathogen or toxin, enters the body it stimulates a class 
of white cells known as B-lymphocyte cells (B cells) to mature into antibody 
producing plasma cells. The plasma cells are triggered by the foreign molecule, 
known as an antigen, into producing antibodies that possess antigen binding 
sites [25].
Once generated, the antibody binds to its specific antigen to form a single com­
plex. In this way, the antibody marks the antigen for destruction by phagocytes, 
which are cells that ingest and destroy marked foreign molecules [25]. Though 
more commonly used to mark molecules for destruction, in some cases the anti­
bodies themselves can destroy pathogens by inducing the formation of hydrogen 
peroxide from oxygen free radicals and water [26].
All of the antibodies that a given B cell secretes have the same specificity for 
the antigen and are called monoclonal antibodies. However, when the immune
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system is challenged with an antigen, many different B cells respond and secrete 
antibodies. Each of these antibodies recognises the antigen but in slightly dif­
ferent ways. These antibodies are known as polyclonal antibodies and comprise 
different specificities and cross-reactivities [26]. Polyclonal antibodies are suitable 
for certain assays such as when a family of toxins is being detected, but increas­
ingly, monoclonal antibodies are desirable. This has resulted in extensive research 
of new methods of producing monoclonal antibodies [27]. One well documented 
method is that of cell fusion, whereby a tumor cell derived from a lymphocyte cell 
is fused with a B cell to form hybridomas [28]. These hybrid cells are immortal 
and proceed to produce monoclonal antibodies indefinitely.
2 .3 .2  A n tib o d y  S tru ctu re
Regardless of whether the antibodies are monoclonal or polyclonal, they possess 
the same basic immunoglobulin structure. The structure is comprised of two iden­
tical heavy polypeptide chains and two identical light polypeptide chains. Both 
the heavy and light chains contain the amino acid cysteine, which is an amino 
acid whose side chain terminates in a sulfhydryl (SH) group. Sulfhydryl groups 
link to each other to form disulphide bonds. In this way, a cysteine in the heavy 
chain links with a cysteine in the light chain to join both chains via a disulphide 
bridge [26]. The resultant antibody structure is illustrated in Figure 2.3, with the 
amine and carboxyl functional groups present at the N-terminus and C-terminus 
respectively indicated (see Section 2.2 for more information).
Figure 2.3: Illustration of antibody structure, indicating the terminal functional
The polypeptide chains fold to form structures called protein domains. Each
“ “ " Heavy Polypeptide Chain 
—  Light Polypeptide Chain 
 Disulphide Bond
COOH COOH
groups.
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light chain is composed of two domains, while each heavy chain is composed of 
four. These domains associate to form three distinct globular portions, resulting 
in a Y-shaped structure (see Figure 2.4).
Figure 2.4: Illustration of antibody Y-shaped structure formed by protein domains 
(Image copyrighted by Mike Clarke, Cambridge University [29]).
The stem of the Y  shape is composed of two heavy chains and is called the Fc 
region. The two domains (labelled C#2 and Ch 3 in Figure 2.5) in this portion 
of the antibody, along with the lower domains of the two arms (C#l and Cl ), 
form the constant region of the antibody common to all antibodies [30]. Each 
of the arms of the Y-shaped structure is comprised of a heavy and a light chain. 
This portion of the antibody is referred to as the Fab portion [31]. As mentioned 
above, the lower domains of the arms are constant regions (Ch 1 and Cl ), while 
the upper domains are variable regions (Vh and Vl ). It is a particular section 
of the variable regions that forms the antigen binding site [30]. Figure 2.5 shows 
a schematic of antibody chains and regions.
2 .3 .3  A n tib o d y  C lasses
Immunoglobulins are classified by the structure of their heavy chains. There are 
five distinct antibody classes found in large mammals; immunoglobulin G (IgG), 
immunoglobulin A (IgA), immunoglobulin M (IgM), immunoglobulin D (IgD) 
and immunoglobulin E (IgE) [28]. The heavy chain of each immunoglobulin is 
referred to by its corresponding lower-case Greek letter, i.e. 7 , a, (i, 5 and e. 
The following descriptions of each of the antibody classes, characteristics and
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Light Chain« Variable Regions
Heavy Chain« Constant Region«
Figure 2.5: Schematic of antibody structure, indicating the locations of chains and
physical properties are taken from Immunology, 6th Edition by Roitt, Brostoff 
and Male [25].
IgG antibodies are the largest class of antibody found in human serum, ac­
counting for over 70 % of the total immunoglobulin pool. They are based on the 
basic four chain molecule structure and are composed of approximately 2-3% 
carbohydrate. A schematic of the IgG antibody structure is shown in Figure 2.6 
(Figures 2.6 to 2.11 reproduced with kind permission from Duane W. Sears [32]). 
It is this particular class of antibodies that was used in the work presented here. 
Details of the specific antibodies employed are given in Section 4.2.2.
regions.
Figure 2.6: Schematic of immunoglobulin IgG structure 
There are four known subclasses of IgG; namely, IgGl, IgG2, IgG3 and
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IgG4 [28]. Though still recognisable as 7  chains, the heavy chain structure of 
each of these subclasses varies slightly from each other. These variations develop 
in order for the antibody subclass to carry out slightly different functions. For 
example, the IgG subclasses found in humans and mice have developed in order 
to carry out functions specific to their hosts’ needs and so are different from each 
other [30]. The main difference between the IgG subclasses occurs in the pattern 
of disulphide bonds linking the two heavy chains. Figure 2.7 shows a schematic 
of the IgG immunoglobulin subclasses.
ajCi WiJ1 ifltW lo«-*
Figure 2.7: Schematic of immunoglobulin IgG subclasses.
After IgG immunoglobulin, IgA is the next largest class of antibody found in 
human serum, accounting for approximately 15-20 % of the total immunoglobulin 
pool. The majority of human IgA antibodies are comprised of the basic four chain 
molecule shown in Figure 2.6. However, in most mammals IgA is usually found as 
a dimer, i.e. formed from two of the basic four chain molecules (see Figure 2.8). 
The two molecules are bound via a peptide chain called a J chain. IgA antibodies 
are the predominant antibody class found in secretions such as saliva and milk, 
with secreted IgA being of the subclass IgAl or IgA2.
IgM is the next largest class of immunoglobulin, accounting for approximately 
10 % of all antibodies found in human serum. It comes in the form of a pentamer 
of the basic four chain molecule, with 12-14% of its content comprised of car­
bohydrate. Like IgA antibodies, it also features a J chain. A schematic of the 
pentamer structure is shown in Figure 2.9.
IgD immunoglobulins are a major component of the surface membranes of 
many B cells but comprise less than 1 % of the total immunoglobulins found in 
human serum. Like IgM immunoglobulins, carbohydrate forms 12-14 % of their
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Figure 2.8: Schematic of imraunogfebulin IgA structure
Figure 2.9: Schematic o f immunoglobulin IgM structure
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content, though the carbohydrates are found in locations different to those on the 
IgM antibodies (see Figure 2.10).
IgE immunoglobulins are the least common antibody type, with only trace 
amounts present in human serum. They are found on the surface membrane of 
mast cells, which are cells involved in the production and release of chemical 
mediators that result in asthma and other conditions [25]. IgE immunoglobulins 
are probably most well known for the part they play in food allergies. It is this 
class of immunoglobulin that initiates the immune response to antigens present 
on protein molecules found in particular foods that cause allergic reactions in 
certain individuals [26]. IgE antibodies have an additional constant region, Ch4, 
as illustrated in the schematic shown in Figure 2.11.
Figure 2.10: Schematic of immunoglobulin IgD structure
Figure 2.11: Schematic of immunoglobulin IgE structure
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2 .4  A n tig e n -A n tib o d y  In tera c tio n
2.4 .1  A n tig en  B in d in g
Each antibody domain is comprised of strands of polpeptide chains. An illustra­
tion of this is shown in Figure 2.12.
V ^ cy3
Figure 2.12: Illustration of antibody structure formed by strands of polypetide 
chains (Image copyrighted by Mike Clarke, Cambridge University [29]).
Antigen binding sites occur at the end of the variable domains, with the 
variable domain of each antibody differing from that of all other antibodies. The 
difference arises as a result of variations in the amino acid sequence of the polypep­
tide chains (predominantly in the binding regions). These variations occur along 
the length of the chains but three specific areas show particularly high degrees of 
variability. These areas are called the hypervariable regions [31].
The three hypervariable regions occur at the loops of the polypeptide chains, 
where the strands change direction. The three regions together are called the 
complementarity-determining regions (CDRs) (see Figure 2.13). Both the vari­
able heavy and light chains contain CDRs, which when combined, form the anti­
gen binding site [30].
Since the CDRs of each antibody vary from one other, the shape of each 
antigen binding site also varies. Antigens can only bind to specific antibodies 
when their surfaces are complementary to the the shape of the antigen binding 
site. This is known as steric compatibility [31]. The portion of the antigen that 
binds to the antibody is called the epitope. There are three distinct ways in which 
it can bind; in pockets, in grooves or along the surface of the antigen binding 
site [31]. In the first case, the entire epitope fits into the binding site. In the 
second case, the epitope slots into the groove between the heavy and light chains
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Anttgan Binding Sit«
Figure 2.13: Representation of antibody variable region, indicating the location of 
the complementarity-determining regions (CDRs). The CDRs (shown as blue loops) 
of both the heavy and light chains combine to form the antigen binding site.
and in the third case the epitope is larger than the binding site but a section of 
its surface conforms to the antigen binding site. The three cases are illustrated 
in Figure 2.14.
(a) (b) (c)
Figure 2.14: Types of conformational binding sites available on antibodies. Anti­
gens are shown in orange, with their epitopes highlighted in red. Image (a) illustrates 
a pocket binding site. Image (b) illustrates a groove binding site. Image (c) illus­
trates a surface binding site (Images copyrighted by Garland Publishing/Elsevier 
Science 2000 [31]).
An element of steric compatibility involves the electron clouds of the antigen 
and antibody. Though the antigen may be structured to fit into the binding 
site, if the antigen’s electron cloud overlaps with areas of the antibody’s electron 
cloud then repulsive forces will come into effect [25]. Antigen association involves 
overcoming these repulsive forces and establishing attractive interactions between 
the antibody and the antigen. The attractive forces involved in the antigen
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binding need to be greater than the repulsive forces in order for binding to occur.
The four non-covalent attractive forces involved in antigen binding are electro­
static forces, hydrogen bonding, van der Waal forces and hydrophobic forces [30]. 
Individually, each of the forces is weak in comparison to covalent bonds. However, 
the large number of interactions involved in the antigen binding results in a large 
total binding energy.
For each of the forces involved, the strength of the bond created is different, 
but in all cases it is inversely proportional to the distance between the antigen 
and antibody. The strength of each of the electrostatic forces, for example, is 
proportional to 1/d2 [25], These are the forces that occur between opposite 
charges. Both antigens and antibodies usually contain many charged amino acid 
side chains, which are affected by these forces [31].
Hydrogen bonding occurs when a hydrogen atom is shared between two elec­
tronegative atoms [31]. The first atom is the proton donor, consisting of a hy­
drogen atom bound to an electronegative atom. A proton acceptor, consisting of 
an electronegative atom with a lone pair of electrons, attracts the hydrogen atom 
to form a hydrogen bond. These bonds stabilise the antibody.
Van der Waal forces are generated by the electron clouds of adjacent molecules. 
Fluctuations in these clouds cause polarisation of nearby atoms. The strength of 
these reactions is proportional to 1/d6 [25].
Hydrophobic forces are the final non-covalent forces involved in antigen bind­
ing. These forces occur between non-polar molecules and water, with the non­
polar molecules being brought together to exclude water. One of the reasons 
for this occurrence is that in the absence of water, the non-polar molecules can 
assume lower, more favourable energy configurations [33].
2 .4 .2  A ffin ity
The sum of all the attractive and repulsive forces acting at an antibody binding 
site is known as the affinity [25]. It is a measure of the strength of the reaction 
between a single antibody binding site and a single antigen. Figure 2.15 illustrates 
the basic concept.
The term avidity is given to the total strength of the antigen binding [25]. 
Antibodies are multivalent, having more than one binding site. For this reason,
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Figure 2.15: Illustration of attractive (black arrows) and repulsive (red arrows) 
forces operating at an antigen binding site.
the avidity of an antibody is often more useful than the affinity. It should be 
noted that the avidity of an antibody for an antigen is greater than merely the 
sum of the individual affinities of each of the binding sites [25]. This is because 
all of the bonds must be broken simultaneously in order for dissociation to occur.
There are several factors that affect affinity and hence the possibility of dissoci­
ation occurring. Changes in pH, temperature and ionic strength all affect affinity 
and so need to be controlled in order to optimise the binding conditions [31].
2 .5  Im m u n o a ssa y s
2 .5 .1  L abel-F ree Im m u noassays
The basis of an immunoassay is the detection of antigens through the use of 
antibodies. Antigens can also be used to detect the presence and concentration 
of antibodies. For simplicity of description, each of the following assays shall be 
described in term of antigen detection.
The majority of immunoassays can be categorised as either labelled or label- 
free immunoassays. Two of the main label-free assays are agglutination assays 
and precipitation assays. In agglutination assays a suspension of antibody-coated 
latex beads forms an opaque solution. The addition of antigen results in the 
binding together of several antibody-coated beads to form minute clumps. Con­
sequently, as the beads are no longer dispersed throughout, the solution changes 
from opaque to clear [28]. The process is illustrated in Figure 2.16.
Precipitation assays are based on a very similar process to agglutination as­
says. When antibodies are mixed with their specific antigen, precipitation occurs
27
2.5. Immunoassays H. M. McEvoy
*  *
*  *
*
*  *  
* *
♦  * a * * *
*
* *
(a) (b)
Figure 2.16: Illustration of the basic concept of agglutination assays. In image 
(a) latex beads coated with antibodies are suspended in solution. In image (b) the 
beads are clumped together due to the addition of antigens into the solution, which 
form links between the antibody coated beads.
and is either visible for detection or measured by its ability to scatter light [30].
Both agglutination and precipitation immunoassays tend to be less sensitive 
than labelled immunoassays i.e. their lower limits of detection are higher than 
those of the labelled assays [30]. One type of label-free immunoassay that is 
capable of low limits of detection is the surface plasmon resonance (SPR)-based 
immunoassay [34]. SPR can be explained as the collective excitation of electrons 
at the interface of a metallic surface and a dielectric [35]. SPR is highly sensitive 
to changes in the refractive index at the boundary. It is this fact that is exploited 
in the majority of SPR-based immunoassays [36-38]. A typical configuration is 
comprised of a glass chip coated with a metallic film, upon which antibodies are 
immobilised. A prism is positioned on the opposite side of the glass chip, with 
a light source located normal to it to ensure that the emitted photons are not 
refracted when they enter the prism. Photons emitted from the light source pass 
through the prism and generate SPR in the metallic layer. When resonance oc­
curs, the reflected light intensity from the metallic layer goes through a minimum 
at a defined angle of incidence. The angle of minimum reflected light intensity 
is recorded using an optical detector such as a photodiode array or CCD camera 
(see Section 3.5 for information on detectors). Antigens specific to the antibodies 
are passed over the surface and bind to the antibodies. In doing so, they increase 
the concentration, and hence the refractive index, at the surface. This results in
28
2.5. Immunoassays H. M. McEvoy
a measurable angular shift in minimum reflected light intensity, which can be used 
to determine the concentration of antigens bound to the immobilised antibodies. 
A schematic of the setup is shown in Figure 2.17.
Figure 2.17: Surface plasmon resonance set-up.
A major advantage of SPR-based immunoassays is that they carry out real­
time measurements, which is not possible with some of the other types of im­
munoassays. There are many commercially available SPR-based immunosensors 
but the most widely used are those developed by BiaCore™ [34] (Upsala, Swe­
den). These are examples of heterogeneous assays, which are assays that can 
discriminate between bound and unbound antigens and therefore do not require 
the unbound antigens to be removed before detection of the bound antigens takes 
place. Homogeneous assays, in contrast, require unbound antigens to be removed 
before detection of bound antigens can take place.
2 .5 .2  L ab el-B ased  Im m u noassays
There are four main types of label-based immunoassays; radiolabelled, enzyme- 
labelled, chemiluminescent-labelled and fluorescently-labelled immunoassays.
Radiolabelled Immunoassays
In radiolabelled immunoassays, antibodies are labelled with radioisotopes. These 
were one of the first types of labels to be used in immunoassays [28]. The ra­
dioisotope decays at a known rate and the emission of the subatomic particles is 
detected using a counter coupled to a photomultiplier tube. The emitted parti­
cles, and hence the counter required, vary depending on the isotope used, though
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most emit ¡3 particles or gamma radiation. The radioisotope Iodine-125 is com­
monly employed. This isotope emits gamma radiation and has a half-life (time 
taken for half the number of radioactive nuclei to decay) of 60 days [28]. Due 
to radiation dose concerns, the stringent controls required and the increase in 
alternative labels, radioisotopes have decreased in popularity over the past few 
decades.
Enzyme-Labelled Immunoassays
One of the most widely used immunoassay types is the enzyme-labelled im­
munoassay [13-15,39-41]. Enzyme characteristics, such as high specificity and 
strong catalytic power, make them very attractive labels. Generally, enzyme- 
labelled immunoassays employ two levels of antibodies; a primary antibody, which 
recognises the antigen and an enzyme-labelled secondary antibody, which recog­
nises the primary antibody. A substrate, which is a chemical entity whose con­
version to a product is catalyzed by an enzyme, is then introduced. The assay 
procedure is shown in Figure 2.18. Depending on the reaction that occurs, de­
tection can be colorimetric, fluorometric or chemiluminescent [42].
Mlcrotitre 
Plate Well
-Antigen
(a) (b)
_ Primary 
Antibody
A  Substrate added ..that reacts with enzyme to change 
colour of solution
(c) (d)
Figure 2.18: Illustration of enzyme-labelled immunoassay.
Two of the most commonly employed enzyme-labelled immunoassays are 
Western Blots and Enzyme-Linked Immunosorbent Assays (ELISAs). In West-
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ern Blots, gel electrophoresis is used to separate proteins of different sizes. This 
is accomplished by passing the sample through a negatively-charged gel. The 
smaller and lighter the proteins, the faster they travel. It must be noted however 
that the charge of the particle can also influence its position in the column. Once 
the proteins have been separated, they are transblotted onto a membrane. This 
is then incubated with specific antibodies, which bind to the protein of interest. 
This is subsequently detected using an enzyme-labelled secondary antibody that 
reacts with the primary antibody. A substrate that gives a coloured product on 
reaction with the enzyme label is then added. An example of the results obtained 
is shown in Figure 2.19.
I 2 3 4 5 6 7 8 « 10 II 12
Figure 2.19: Results from a Western Blot assay. Charged gel is used to separate 
proteins by weight. Their presence is then indicated using enzyme-labelled antibod­
ies. Column 1 is a negative control, column 2 is a set of molecular weight markers, 
columns 3-5 are chicken sera containing the antibody of interest and columns 6- 
12 are chicken sera not containing the antibody of interest. Protein weights (in 
kilodaltons) are indicated on the left.
ELISAs are typically carried out using microtitre plates, which are polymer 
plates containing 96 or 384 wells. The antigens of interest are immobilised in 
the wells and secondary, enzyme-labelled, antibodies are added. A substrate is 
then added to each well, where it reacts with the enzyme, resulting in a colour 
change of the solution. Each well can be coated with varying concentrations of 
antigen, with the same concentrations of primary and secondary antibody added 
to each. ELISAs are used extensively for a wide variety of tests, including HIV
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screening [43]. A disadvantage of using enzyme-labelled immunoassays is that 
they can be inhibited by certain factors. For example, horse radish peroxidase 
(HRP), which is one of the most commonly employed enzymes, is inhibited by 
sodium azide (NaNa), which is regularly used in antibody solutions to prevent 
bacterial growth [28]. It is also inhibited by O2 and CI2 and is found in serum 
and other important analytical matrices [28].
Chemiluminescent and Bioluminescent Immunoassays
Chemiluminescence is the emission of light caused by a chemical reaction [28]. 
Two or more compounds react to create an excited state, which on decaying to 
the ground state, emit photons. Bioluminescence is a form of chemiluminescence, 
where the compounds involved in the reaction are found in living organisms [5].
The light emitted often only lasts for a few seconds. For example, reacting 
acridium ester with OH“ and H2O2, results in a burst of light that lasts for 
approximately 5 seconds [28]. Reagent addition must be fast and extremely 
precise because the reaction occurs so quickly. In some cases, this can be overcome 
by using an enhancer to extend the light emission time. For example, using the 
chemical enhancer p-iodophenol with the reagents peroxidase, luminol and H2O2, 
results in a light emission that lasts longer than 30 minutes [28].
Chemiluminescent assays are extremely sensitive to factors that influence the 
recorded signal, such as background, inhibitors and enhancers. The purity of the 
reagents used and the cleanliness of equipment must be strictly controlled.
Fluorescently-Labelled Immunoassays
In fluorescently-labelled immunoassays, the labels used are fluorescent molecules, 
known as fluorophores. These molecules absorb light of a particular wavelength, 
which raises them to an excited state. They then revert to their ground state, 
emitting light of a second and higher wavelength. This process will be explained 
in detail in Chapter 3.2.
It was this form of assay that was employed in the immunosensor presented 
here. Some of the reasons for this choice include the fact that, unlike surface 
plasmon resonance-based immunoassays, fluorescently-labelled immunoassays do 
not require the use of a metallic substrate, which gives the fluorescent immunoas­
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says an extra degree of versatility with regards to substrate choice. There are 
no safety concerns with the use of fluorophores, as opposed to concerns over 
radiation doses when using radioisotopes as labels. Unlike enzyme and chemi- 
luminescent labelled immunoassays, fluorescently-labelled immunoassays do not 
require a second reagent for the reaction to occur. Fluorophores are also easily 
attached to proteins, are very stable and are readily available in a wide range of 
wavelengths, which increases the multianalyte capabilities of the immunosensor. 
Finally, fluorescence is intrinsically a highly sensitive process, which implies that 
fluorescently-labelled immunoassays are capable of achieving very low detection 
limits.
2 .5 .3  A ssay  F orm ats
There are four main immunoassays formats: direct binding, competitive, dis­
placement and sandwich assay. Direct binding assays are the simplest to per­
form. Antibodies specific to the antigen of interest are immobilised on the sensor 
surface. Antigens are introduced and bind to the antibodies. The antigens are 
either labelled or induce a measurable change in the sensor (e.g. refractive in­
dex change). This assay can also be performed by immobilising antigens on the 
sensor surface and allowing antibodies to bind to them. The format is shown in 
Figure 2.20.
Labelled ____ ^
Antigen
Antibody
Sensor ____
Substrate
Y Y
Figure 2.20: Schematic of direct binding assay format.
Sandwich assays also involve the immobilisation of antibodies, followed by the 
attachment of antigens but in this case the presence of the antigen is detected by 
a second, labelled antibody. Figure 2.21 illustrates the binding format.
For sandwich assays to be effective, the antigen of interest must be large
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Labelled
Antibody
Antigen
Figure 2.21: Illustration of sandwich assay, showing antigen sandwiched between 
labelled antibody and binding antibody.
enough, with sufficient available epitopes, to bind two antibodies simultaneously. 
A major advantage of this double binding is a reduction in the number of false 
readings. This is due to the fact that in order for an antigen to be detected it 
must bind to not just one, but two separate antibodies.
Antigens too small to stimulate antibody production are called haptens. They 
are typically less than 10,000 Daltons in weight. Daltons (Da) are atomic mass 
units used in biochemistry and molecular biology, with 1 Da =  1 g mol-1 [33]. In 
order for the haptens to be detected, it is necessary to conjugate (bind) them to 
larger carrier proteins [31]. Antibodies specific to the hapten conjugates can then 
be generated and sandwich assays carried out as described above.
A major advantage of sandwich assays is that, provided the antigen is large 
enough, they can provide signal amplification. A number of labelled antibod­
ies can attach to each bound antigen. This means that the presence of each 
antigen is indicated by not one but several labelled antibodies. The principle is 
illustrated in Figure 2.22.
Unlike sandwich assays, competitive assays are capable of detecting antigens of 
less than 10,000 Daltons. In competitive assays labelled and unlabelled anti­
gens compete for antibody binding sites. Antibodies are immobilised on the 
sensor surface and a known quantity of labelled antigen is introduced, along with 
a test sample containing an unknown amount of antigen. The concentration of 
antigen in the test sample is determined by comparison with an inhibition curve 
that is generated by measuring the response from different fixed amounts of la-
34
2.5. Immunoassays H. M. McEvoy
Large
Antigen
Figure 2.22: Illustration of amplification capability of sandwich assay. The presence 
of each antigen is indicated by not one but several labelled antibodies.
belled antigen and unlabelled antigen. A schematic of the assay format is shown 
in Figure 2.23.
One possible drawback of competitive assays is that there axe several sample 
preparation steps, including labelling and mixing. This may not be a problem for 
some assays or immunosensors but it must be considered when deciding on the 
most suitable assay format.
The final immunoassay format is that of the displacement assay. These as­
says require immobilised antibodies to be saturated by labelled antigens. When 
a test sample containing the antigen of interest is introduced, the unlabelled 
antigens displace the bound labelled antigens. The quantity of antigens in the 
test sample can be determined by measuring the quantity of displaced labelled 
antigens. Figure 2.24 illustrates the process.
Figure 2.23: Illustration of competitive assay.
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Figure 2.24: Illustration of displacement assay.
2 .6  C o n c lu sio n s
This chapter has detailed the sensing mechanism of the immunosensor developed 
in this work. Antibodies were introduced and described in terms of both their 
function and structure. The mechanisms involved in antigen binding were ex­
plained, with reference to the composition of antigen binding sites and the forces 
employed. In the final sections of the chapter, descriptions of the main immunoas­
say categories and formats were provided and reasons were given for the choice 
of fluorescently-labelled immunoassays.
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Chapter 3
Fluorescence Sensing: Principles 
and Techniques
3.1  In tr o d u c tio n
The immunosensor presented in this work is based on the detection of fluores­
cence from labelled antibodies or antigens. This chapter will detail the principles 
and techniques involved in fluorescence sensing. Fluorescence emission will be 
explained, along with references to fluorophores. Typical excitation sources and 
methods will be described. A detailed theoretical analysis of the two main exci­
tation principles employed in the immunosensor presented here namely, waveg- 
uiding and evanescent field excitation, will be presented. Finally, a description 
will be provided of the fluorescence detection systems most commonly employed 
in fluorescence-based biosensors.
3 .2  P h o to lu m in e sc e n c e
Photoluminescence occurs when photons are absorbed by an atom and subse­
quently re-radiated. It is caused by the photons interacting with the electrons 
of the atom and raising them to higher energy levels. In the process of return­
ing to their ground level the electrons emit energy as photons. The principle is 
illustrated in Figure 3.1.
Photoluminescence is usually categorised as either phosphorescence or fluores-
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Absorption Excitation of electron
Figure 3.1: Illustration of principle of photoluminescence
cence. In the case of phosphorescence, the emission of light continues for a signif­
icant time (seconds) after the excitation has ceased, whereas for fluorescence, the 
emission of light occurs only over a short time scale (a typical emission lifetime 
is 10 ns) [1]. The reason for this difference is due to the behaviour of the excited 
electrons and the relative transition probabilities of the optical transitions.
In the case of fluorescence, when electrons in the ground state (S 0) are excited 
by photons, they are raised to higher energy levels such as the first or second states 
(Si or S?). This is illustrated in the Jablonski diagram shown in Figure 3.2.
Second Singlet—  —
State (S2) ------------------------
Figure 3.2: Jablonski diagram illustrating the emission of fluorescence and phos­
phorescence due to electron transitions from excited states to ground states.
After the initial excitation, internal conversion to the lowest first state occurs, 
followed by the electrons returning to the ground state, emitting photons in the 
process. In the case of fluorescence, the internal conversion to the lowest first
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sta te  occurs in approxim ately 1 0 _ 12s. This is several orders of m agnitude faster 
th an  the emission of fluorescence, which takes approxim ately 1 0 -8s [1 ],
In the case of phosphorescence, after excitation to  a higher state , the electrons 
de-excite to  the first trip let sta te  [1]. Transition from this sta te  to  the ground 
sta te  is forbidden. As a  consequence, the atom  emits over a longer period as the 
electrons return  to  the ground sta te  via low-probability processes. Such processes 
can include interaction with other molecules in the same trip let sta te  or therm al 
energy raising the electron to  a  sta te  from which it can de-excite [2 ].
For both fluorescence and phosphorescence, the am ount of energy released 
during the relaxation to  the ground sta te  is less than  th a t absorbed, meaning 
th a t  the em itted light occurs a t a higher wavelength (lower energy) th an  the 
excitation light. The difference in wavelength between absorbed and em itted 
light m axima is called the Stokes’ Shift [1]. The absorption and emission spectra 
of the dye P t(II)Porphyrin  is shown in Figure 3.3, w ith Stokes’ Shift indicated 
by the blue arrow.
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Figure 3.3: The absorption and emission spectra of the dye Pt(ll)Porphyrîn. 
Stokes' Shift is indicated by the blue line.
3.3 Fluorophores
Fluorophores are fluorescent molecules used as tags or labels in optical detection 
systems. There are two m ain features common to all fluorophores. The first is the 
obvious requirem ent th a t  they produce fluorescence when excited a t a particular 
wavelength. The second is th a t  fluorophore molecules contain functional groups
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th a t  allow them  to easily bind to  the molecule to  be detected. O ther desirable 
a ttribu tes include high absorptivity, high fluorescence quantum  yield, water solu­
bility, pH insensitivity, low photobleaching (irreversible reduction of fluorophore 
intensity after sustained excitation) and low quenching upon conjugation (bind­
ing) to  the host molecule.
The m ost commonly employed fluorophores in fluorescence biosensing include 
fluorescein, rhodam ine and cyanine. The reason these are m ost widely used is 
due to  the fact th a t they exhibit several of the above characteristics. Fluorescein, 
along with its m ost widely used derivative, fluorescein isothiocyanate (FITC), 
has relatively high absorption coefficient, excellent fluorescence quantum  yield 
and good water solubility. Its excitation maximum of 495 nm  closely matches the 
488 nm  spectral line of argon-ion lasers, which are often used in confocal laser- 
scanning microscopy and flow cytom etry applications. Some of its drawbacks 
include its relatively high rate  of photobleaching and the fact th a t its fluorescence 
is significantly reduced below pH7.
For the work presented here, cyanine dye was employed as the fluorescent 
label. The particu lar derivative used was Cy5, which is a fluorescent bifunctional 
NHS-ester, meaning th a t it has two amine binding sites. This facilitates binding 
of the Cy5 dye to  antibodies, which have several available amine groups. The 
dye is also highly water soluble, which is an im portant requirem ent of the label, 
as antibodies are stored in aqueous solutions. O ther advantages of Cy5 dye 
include its improved photostability compared to  other dyes and the fact th a t it 
is insensitive to  pH over a broad range.
As shown in the  absorption and fluorescence emission spectra in Figure 3.4, 
Cy5 dye can be excited between 600 nm and 660 nm  and emits an intense flu­
orescence in the far-red region of the visible spectrum  (with a maximum signal 
a t 670nm ). This means th a t  low-cost, commercial, red laser diodes (see Sec­
tion 3.4.1 for a detailed description of laser diodes) can be used as the excitation 
source.
A ruthenium  dye complex, R u(dpp)3 , was also employed for the work pre­
sented in Chapter 5, and will be described in detail in th a t Chapter.
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Figure 3.4: Absorption and emission spectra of Cy5 dye.
3.4 E xcitation
3 .4 .1  E x c ita tio n  Sources
Two m ain excitation sources were used in the work presented here. The first 
was a  light em itting diode (LED), which is one of the m ost commonly employed 
excitation sources for sensing applications. LEDs are based on semiconductor 
p-n junctions or diodes. W hen the  LED is forward biased, the electron-hole 
recom bination gives rise to  intense emissions across the bandgap of the material. 
Some of the reasons for the popularity  of LEDs include the fact th a t they are small 
in size, inexpensive and have low power consumption. A few of the drawbacks 
associated with LEDs are th a t  the em itted light is incoherent, uncollimated and 
is of a  relatively broad bandwidth.
The second excitation source used in the work presented here was a laser diode. 
Laser diodes are simply LEDs th a t have been designed to  produce coherent laser 
light. Like LEDs, they  are small in size and, due to  their low power consumption, 
can be powered by batteries. This makes them  suitable for inclusion in portable 
sensor systems.
The excitation sources used in the work presented here were m atched to  the 
excitation m axim a of the dyes employed. A 635 nm  laser diode was used as the 
excitation source for the sensors employing Cy5 dye and a blue LED (460 nm) 
was used as the excitation source when the ruthenium  dye complex, R u(dpp)3 , 
was employed.
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3 .4 .2  W aveguid ing
One of the immunosensors developed in this work employed a waveguide as the 
sensor substrate , facilitating the use of evanescent wave excitation.
An optical waveguide is a dielectric medium th a t confines and guides optical 
electrom agnetic waves [3]. Of particular interest to  this work is the planar config­
uration, w ith an asymm etric slab waveguide being a commonly employed format 
e.g. a  glass microscope slide coated with sensing layer [4], The term  asymmetric 
refers to  the fact th a t the refractive index of the medium above the waveguide 
differs from the refractive index of the medium below. For ease of explanation, 
in this treatm ent the media above and below the waveguide shall be referred to 
as the layer and substra te  respectively.
A generalised asymm etric slab waveguide is depicted in Figure 3.5, with nj, 
n w and n s denoting the refractive indices of the layer, waveguide and substrate 
respectively. The thickness of the waveguide is indicated by d and the incident 
angle by 8.
X Layer, ri|
/ y n  \
i \
z  y ^ Waveguide, nw
Substrate, n s
Figure 3.5: Schematic of an asymmetric slab waveguide.
A ray of light is guided down the length of the waveguide via to ta l internal 
reflection. Total internal reflection occurs when the incident angle is greater than  
the critical angle [5]. From Snell’s law, the critical angle is defined as:
6C — sin_1(— ) (3.1)
where n 2 denotes the  medium of higher refractive index and n i the medium of 
lower refractive index.
Therefore, the critical angles a t the waveguide-layer interface and the waveguide- 
substra te  interface can be defined as:
0c =  sin_1(— ) (3.2)
Tly j
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If n/ >  n s, which is the case in the work presented here, then 9j > 9,.s. This 
results in three possible angular ranges of 0:
1 . 90° >  6 > 9c : In this case, to tal internal reflection occurs a t both the 
waveguide-layer interface and the waveguide-substrate interface, resulting 
in a guided mode. This is illustrated in Figure 3.6.
Layer, ri|
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Figure 3.6: Guided mode.
2. 9 l>  9 > 9c : In  th is case, to ta l internal reflection occurs a t the  waveguide- 
substra te  interface b u t the  light is free to  leak into the layer as w hat is 
known as a  “cover mode” (illustrated in Figure 3.7).
Figure 3.7: Cover mode radiation.
3. 9 < 9C“ : If the incident angle is lower than the critical angle a t both 
interfaces then the light is free to leak into both the layer and the substrate. 
An illustration of the resultant “substra te  cover mode” radiation is shown 
in Figure 3.8.
Of the three angular ranges indicated, only the first allows waveguiding to 
occur over an extended distance.
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Figure 3.8: Substrate-cover mode radiation.
3 .4 .3  E van escen t W ave E x c ita tio n
W hen light propagates in a  waveguide, an exponentially decaying tail of the field 
extends into the surrounding media. This is known as the evanescent field and is 
illustrated  in Figure 3.9 [3].
Layer, n|
Waveguide, nw 
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Figure 3.9: Illustration of exponential decay of evanescent field.
The field decays exponentially w ith distance from the waveguide according to 
the relation:
E  ~  £ " e x p ( ^ )  <3-4) 
where E  and z  are th e  electric field am plitude and distance from interface respec­
tively. The penetration  depth, dp, is the perpendicular distance from the interface 
a t which the  wave am plitude falls to  1 /e  of its initial value a t the interface (.Eo). 
T he m agnitude of dp is given by:
dp 2Tmw(sin2 0 -  (ni/nw)2y /2 3^‘5^
where 9 refers to  the angle of incidence and all other symbols are as previously 
described.
As can be seen from Equation 3.5, dp is dependent on refractive index, wave­
length and incident angle, which means th a t dp can be tuned by varying these
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param eters. This has significant implications for sensing. The evanescent field 
can be used to  selectively interact w ith entities a t the waveguide surface. By tu n ­
ing dp, labelled molecules bound to  the surface of the waveguide can be excited 
w ithout exciting non-bound labelled molecules in the solution above, which lie 
out of the range of the evanescent wave.
In the initial immunosensor presented here (see Chapter 4), evanescent wave 
excitation is used to  selectively excite surface-bound labelled antibodies.
3 .4 .4  C ou pling
As the penetration depth  of the evanescent field is dependent on the angle of 
incidence, it is necessary to  have precise control over the coupling of light into 
the waveguide. Prism  coupling, b u tt coupling and grating coupling are examples 
of some of the more commonly employed m ethods [6 ].
Initially, grating coupling was employed as the m ethod of coupling for the 
first immunosensor presented in this work. This involved the fabrication of a sol- 
gel-based, periodic grating on the surface of a waveguide. The grating facilitated 
the phase m atching of the incident beam  with particular waveguide modes. Due 
to the low coupling efficiencies and high incident angle dependency of grating 
coupling this m ethod was subsequently replaced with an alternative coupling 
m ethod.
The m ethod chosen was th a t  of direct focusing, also referred to  as end-fire 
coupling. End-fire coupling is a form of transverse coupling, where the incident 
beam  of light is incident directly onto the exposed cross-section of the waveguide. 
Coupling occurs by m atching the  beam-field, e.g. Gaussian profile of laser beams, 
to  the waveguide mode field [7]. Focusing of the incident beam  is necessary to 
m atch its profile to  th a t of the waveguide mode field. This aids in the reduc­
tion of energy loss into scattered fields. A schematic of the m ethod is shown in 
Figure 3.10.
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Figure 3.10: Schematic of coupling o f a light beam into a waveguide using the
end-fire coupling method.
3.5 F luorescence D etection
3.5 .1  C C D  C am era
Charged coupled device (CCD) cameras are widely used for 2D detection. These 
are m etal oxide semiconductor-based devices comprised of rows and columns of 
pixels, each of which converts photons into electrons. Photons striking the CCD 
surface excite the individual elements, elevating electrons to  higher energy levels, 
eventually producing free charge. A  positive voltage applied to  an electrode at 
the pixel a ttrac ts  the  negatively charged electrons close to  the area under the 
electrode and also repels any positively charged holes from the area. This forms 
a “potential well” beneath  the electrode. The quantity of electrons collected 
(charge) is dependent on the num ber of photons striking the CCD, w ith a typical 
well capable of collecting 1 0 0 , 0 0 0  electrons before being saturated.
Though only a single electrode is required to  form a potential well, each pixel 
consists of three electrodes. This facilitates the transfer of the charge out of the 
CCD, in order for it to  be quantified. In order to  collect the  electrons, a positive 
voltage is applied to  one of the electrodes. This is referred to  as holding the 
electrode high (e.g. applying 12 V). The other two electrodes are kept low (e.g. 
0 V). Once the charge is collected it can be moved by changing one of the  low 
voltages to  high. The charge is now shared between the two high electrodes. 
Reverting the initial electrode back to  low ensures th a t the charge is transferred 
to  the  new electrode. Repeating the process will result in the charge progressing 
either down a column of pixels or across a row, depending on the orientation of 
the electrodes.
In the m ajority  of CCD cameras, electrodes are arranged so th a t  charge is
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transferred downwards along the columns until it reaches the final row, where 
it is transferred off the CCD. It is then  amplified and converted into a voltage. 
These voltages are then  converted from analogue values into a digital form by the 
cam era electronics, resulting in a 2D intensity image of the CCD array.
A t room  tem perature, therm ally generated noise, referred to  as dark  current, 
can result in the  generation of thousands of electrons per pixel per second. Con­
sequently, full well capacity of each pixel is reached within a few seconds. Cooling 
CCDs can significantly reduce the noise to  only tens of electrons per pixel per 
second. Therefore, CCD cameras are often cooled in order to  improve their per­
formance.
3 .5 .2  C M O S C am era
Com plem entary m etal oxide semiconductor (CMOS) cameras are similar in design 
and function to  CCD cameras. The m ain difference lies in the electron to  voltage 
conversion. In CCD cameras, this occurs after the collected charge has been 
removed from the pixel columns. However, in CMOS cameras, electron to  voltage 
conversion takes place a t each pixel and it is the voltage th a t is transferred along 
the columns.
In general, CMOS cameras offer superior power consumption compared to 
CCD cameras and due to the fact th a t less off-chip circuitry is required, they 
are typically smaller in size. These advantages are usually offset by the superior 
noise performance of CCD cameras, which occurs as a result of their employing 
less on-chip circuitry.
Both CCD and CMOS cameras were employed in this work.
3.6 C onclusions
In th is chapter, the optical phenom ena relevant to  the development of the im- 
munosensor reported in this work have been presented. Fluorescence was de­
scribed in term s of electron activity and explained with the aid of energy level 
diagrams. A brief overview of fluorophores was provided. Excitation sources 
commonly employed in fluorescence-based biosensors were explained. The prin­
ciple of waveguiding was introduced and the conditions under which it can occur
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were stated . Evanescent wave excitation was explained and the im portance of 
its tunable penetration depth was highlighted. The strategy by which light was 
coupled into the sensor platform  was outlined and finally, each of the fluores­
cence detection sources employed in the work presented here were described and 
compared.
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Chapter 4
D evelopm ent o f Planar 
Im m unosensor
4.1 Introduction
In order to  successfully achieve the  objective of developing a  generic, low-cost, 
effective immunosensor, it was necessary to  investigate and combine a  range of 
experim ental techniques, namely, immobilisation strategies, pattern ing  methods, 
optical excitation and detection and image analysis. This chapter describes the 
development and integration of these techniques to  yield a planar optical im­
munosensor.
4.2 A n tib od y  Preparation
4 .2 .1  A ssay  Form at
The assay form at chosen for the immunosensor presented here was th a t of a 
sandwich assay. As described in Section 2.5.3, the first stage of a sandwich assay 
is the  imm obilisation of capture antibodies on the sensor substrate. The antigen of 
interest is then  introduced and binds specifically to  the immobilised antibodies. 
The presence of the  antigen is indicated by introducing fluorescently-labelled 
antibodies, which a ttach  to  the bound antigens. Using an appropriate detector, 
the fluorescence signal is imaged and correlated to  the antigen concentration. The 
overall assay configuration is illustrated  in Figure 4.1.
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Labelled ___
Antibody
Antigen
Figure 4.1: Sandwich assay format, illustrating an antigen sandwiched between 
labelled antibody and binding antibody.
There were several reasons for choosing this sandwich assay format. It is 
a relatively simple assay to  perform, with each of the solutions (i.e., antibody, 
antigen and labelled antibody) being introduced separately. The main advantage 
of this assay is th a t  the  antigen does not need to  be mixed or labelled. One 
possible drawback of using a sandwich assay form at is th a t, unless the antigen is 
coupled to  larger molecules, only relatively large antigens are capable of being 
detected. This is due to  the fact th a t the antigen m ust a ttach  to  both  the capture 
antibody and the labelled antibody (see Section 2.5.3 for more information). 
However, binding to  two antibodies also provides an advantage over other assay 
form ats as it helps to  reduce the num ber of false readings, due to the fact th a t 
antigens are detected  only when they bind to two separate antibodies.
4 .2 .2  A n t ib o d y /A n t ig e n  S e lection
The initial an tigen /an tibody  pair chosen to  dem onstrate the proof of principle 
immunosensor was th a t  of bovine serum album in (BSA) and its corresponding 
antibody; anti-BSA. A lbum in is the most common protein in blood plasma, with 
BSA being the m ost common protein in bovine blood plasma. There were several 
reasons for choosing this antigen and corresponding antibody.
W ith  a  mass of approxim ately 60 kDa and a  diam eter of approxim ately 6  nm, 
BSA was large enough, w ith sufficient epitopes to  bind to  two antibodies simul­
taneously. This facilitated the use of the sandwich assay format. BSA is readily
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available in its purified form and relatively large quantities (grams) can be pur­
chased a t a relatively low cost. This is unlike many other antigens th a t are quite 
expensive and available only in /ig quantities. The reason BSA is so readily avail­
able is due not only to  the fact th a t it is the most common protein in blood 
plasm a but th a t it is also a good immunogen, meaning th a t it generates a large 
quantity  of high affinity antibodies. As a result of its availability and good im­
munogenic properties, BSA is well characterised, m aking it a good choice for the 
development of the proof of principle immunosensor presented here.
4 .2 .3  P u r ifica tion
In order to  increase the antibody specificity, the anti-BSA antibodies were affinity- 
purified before being immobilised on the substra te  surface. A polymer cylindrical 
column w ith an opening a t one end and a narrow outlet a t the other was filled 
with Sepherose gel linked with BSA. Sephersose gel (AGB, Dublin) is comprised 
of polymer beads of sufficient diam eter to  allow labelled-antiBSA antibodies to 
filter slowly between the beads once they are packed into the column. Tubing 
was attached to  the outlet a t the base of the column and connected to a flowcell 
positioned in a UV spectrom eter. Anti-BSA antibodies were then injected into 
the column and, after 20mins, phosphate buffer saline (PBS) Tween was passed 
through the column to  remove unbound antibodies. PBS was then  passed through 
to  remove any traces of PBS Tween. In order to  break the bonds between the 
BSA molecules and anti-BSA antibodies, a solution of low pH (referred to as 
an elution buffer) was passed through the column. The antibody solution was 
collected in aliquots after it had passed through the flowcell and spectrom eter 
(which was used to measure the absorbance of the eluted solution a t 280 nm). 
Anti-BSA antibodies absorb at 280 nm  and, as a consequence, a high absorbance 
corresponds to  a solution containing a high concentration of antibodies specific 
to  BSA.
4 .2 .4  A n tib o d y  L abelling
Purified antibodies were divided into two separate solutions. The first solution 
was used as the capture antibody stock and the second solution was used for the 
antibody labelling step. The label chosen for use in the immunosensor presented
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here was the cyanine dye, Cy5, which was explained in detail in Section 3.3. 
The Cy5 dye was added to  pH9.3 buffer solution containing the antibodies and 
incubated a t room tem perature. After 30mins, w ith additional mixing of the 
solution every 1 0  mins, the antibodies were fully labelled.
Separation o f labelled  antibody from free dye
Upon completion of labelling, it was necessary to  remove any unconjugated dye 
in order to  prevent it from interfering w ith antigen attachm ent or giving rise to 
false readings.
In order to  separate the antibody from the free dye, two different m ethods 
were employed. The first m ethod was dialysis. The labelled antibody solution was 
p ipetted  into dialysis tubing, which was then sealed a t bo th  ends. The dialysis 
tubing contained pores of a size th a t allowed passage of free dye but blocked the 
larger dye-labelled antibodies. The filled tubing was stirred in a pH7 PBS solution 
overnight. This stage was carried out in a cold room  as prolonged storage of the 
antibody solution a t room  tem perature results in a  reduction in antibody activity. 
After stirring, unbound dye present in the antibody solution had filtered through 
the tubing into the PBS solution, leaving only labelled antibody remaining within.
The second free dye separation m ethod employed was Gel Perm eation Chro­
m atography (GPC). In G PC, a glass cylinder (typically 10mm in diam eter and 
500 mm to 1000 mm in length) is packed with beads of a known pore size and 
solvent is passed through. The sample requiring separation is dissolved in the 
same solvent and added to  the column. The ra te  of passage of the molecules 
present in the  sample is affected by their size. Molecules larger th an  the pores 
continue following the solvent flow. However, diffusion causes molecules smaller 
than  the pores to  be drawn into the beads before continuing down the column. 
Consequently, molecules larger than  the pore size reach the base of the column 
before molecules th a t are smaller th an  the pore size.
In order to  remove the free dye from the labelled antibody solution, a GPC 
column was packed w ith polystyrene beads w ith pore sizes larger than  Cy5 dye 
but smaller th an  the  labelled antibodies. PBS was passed through the column and 
the antibody solution was then  added. Two bands were formed, each travelling at 
a different ra te  through the column. The first contained the labelled antibodies,
58
4-2. Antibody Preparation H. M. McEvoy
w ith the second being comprised of the dye molecules. This formation of two 
bands perm itted  the labelled antibodies to  be collected separately from the free 
dye. The process is illustrated  in Figure 4.2
Glass _
Cylinder
Polystyrene
Beads
Collection__
Tube
Figure 4.2: Separation of free dye from labelled antibody using a gel-filtration 
column.
C alculation o f D ye to  A ntib ody  R atio
G ruber et al. dem onstrated reduced fluorescence emission for IgG antibodies 
labelled w ith 6  dye molecules when compared to  antibodies labelled w ith fewer 
dye molecules [1]. Therefore, for the antibodies employed in this work, it was 
decided to  use a  dye to  antibody ratio  of less th an  6 .
I t was not possible to  quantify the exact num ber of dye molecules attached 
to  each anti-BSA antibody but the average num ber was calculated from the ratio 
of the  dye and antibody molecular concentrations. The molecular concentrations 
were determ ined using the  dye and antibody absorption values and their molar 
extinction coefficients.
The molar extinction coefficient of Cy5 dye is supplied by the m anufacturer as 
250,000 M _ 1 cm _ 1  a t 650 nm. It is m easured at 650 nm  as th is is the wavelength 
a t which m axim um  absorbance occurs. As the m olar extinction coefficient varies 
for each antibody, there  is no standard  value. However, from Equation 4.1 (Beer- 
Lam bert Law), the  slope of the straight line plot of antibody concentration versus
Slow-moving 
Free Dye
Fast-moving
Labelled-antibodie
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absorption is equal to  the molar extinction coefficient (when 1 equals 1 cm).
A  =  eel (4-1)
where A  represents absorbance, e is the molar extinction coefficient, c is the 
antibody concentration and 1 is the optical pa th  length. Therefore, plotting ab­
sorption a t 280 nm  for one of the batches of labelled anti-BSA antibodies used in 
this work (as the antibody absorption maximum occurs a t this wavelength), the 
antibody molar extinction coefficient was determ ined to  be 166,270.
Following the determ ination of the extinction coefficient, the molar concen­
tra tions of the dye and antibodies were calculated using Equations 4.2 and 4.3. 
These are m anipulations of the Beer-Lam bert Law, using an optical pa th  length 
of 1  cm (as absorbance values were determ ined using a cuvette of 1  cm diam eter).
[Cyb] =  (4.2)
^cfa/e@6 50
[Antibody] =  X” ° ~  10 ' ° 5  X '4 ti°l (4.3)
^antibody©  280
where [Cyh] represents the molar concentration of Cy5 dye, [Antibody] repre­
sents the molar concentration of the labelled antibody solution, and all other 
symbols are as previously described. As antibodies do not absorb at 650 nm, the 
absorption th a t occurs a t 650 nm  is entirely due to  the Cy5 dye. However, the 
absorption th a t  occurs a t 280 nm, though mainly due to  the antibodies, is also 
partially  due to  the dye. The dye m anufacturer states th a t the dye absorption at 
280 nm  is approxim ately 5 % of the absorption at 650 nm  (hence the modification 
factor in Equation 4.3).
Substitu ting the absorption values and extinction coefficient yields:
[Cÿ51 = l ^ l  = 3'5728xl0_6M <4 4 )
Similarly,
L y j 166,270 v ’
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Consequently, the  dye to  antibody ratio  becomes:
Pvt = 3-573 >< 10~6 =  4 (4 .6)
Antibody  8.934 x 10- 7  
Therefore, for this particular example, 4 dye molecules attached to  each antibody.
4 .2 .5  D e term in a tio n  o f  A n tib o d y  A c tiv ity
For the immunosensor to  work effectively, it was essential th a t the range over 
which the antibody was sensitive to  the antigen of interest was determined. Too 
few antigens present in the sample could result in no change in sensor response, 
while too m any antigens could result in saturation of the binding sites.
The activity (sensitivity to  BSA) of the anti-BSA antibodies was determined 
using an Enzyme-Linked Im m unosorbent Assay (ELISA) (see Section 2.5.2 for 
more information on ELISAs). M icrotitre plates were coated with 10/xg/mL of 
BSA in PBS. Once immobilised and shaken to  remove unbound molecules, the 
plates were then  coated w ith Milk M arvel (Chivers, Ireland) solution. This con­
tains proteins of various sizes, which occupy areas on the plate uncoated by the 
BSA. W ashing steps of PBS Tween and PBS were used to  remove any unbound 
molecules. Dilutions of anti-BSA antibodies in PBS (from 1/200 to  1/1000000) 
were added to  different wells of the m icrotitre plates and incubated to  facilitate 
binding. Following binding, the plates were washed and a secondary, enzyme- 
linked antibody was added to  each well. In this work, goat anti-rabbit Horse 
Radish Peroxidase conjugated antibody was used. After further incubation and 
washing, Peroxidase Substrate was added, which reacted w ith the enzyme-linked 
antibody. Horse Radish Peroxidase Substrate absorbs a t 450 nm. Therefore, mea­
suring the absorbance of each well a t this wavelength, perm itted  the quantity of 
substra te  (and consequently the  quantity  of antibody) present to  be determined. 
A typical antibody activity graph obtained is shown in Figure 4.3.
Each point on the  graph shown in Figure 4.3 corresponds to  a different di­
lution of anti-BSA antibodies. The graph shows the limit a t which a change 
in antibody concentration is no longer detectable. This value is known as the 
antibody titre . In Figure 4.3 the titre  occurs a t approxim ately a 1/100000 anti­
body dilution. Below this value, though the concentration of antibody decreased, 
no detectable change in absorbance was recorded.
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Figure 4.3: Activity graph of anti-BSA antibodies, measured using an Enzyme-
Linked Immunosorbent Assay.
The graph was used to  determ ine the  optim um  concentration of antibody to 
immobilise on the immunosensor substra te  surface. The concentration th a t re­
sulted  in  an absorbance equal to  half the m aximum  absorbance value (referred to 
as the 1 / 2  m ax value) was chosen as the  compromise between detectable signal 
and presence of excess antibodies. The 1/2 m ax value in Figure 4.3 lies a t ap­
proxim ately 1/5000. Therefore the  antibody stock solution was diluted by 5000 
before being immobilised on the  substrate.
4.3 Im m obilisation
4 .3 .1  A n tib o d y  F u n ction a l G roups
T he assay required the immobilisation of capture antibodies onto the substrate 
surface. It is possible to  physisorb antibodies onto substrates (as occurs on the 
m icrotitre plates employed in ELISAs) bu t this is an unstable, uncontrolled a t­
tachm ent. In order to  control surface coverage and antibody orientation it is 
necessary to  covalently a ttach  the antibodies to  the sensor substrate.
The m ajority  of IgG antibodies (the class used here) include side chains con­
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taining amine groups or hydroxyl groups but due to  the intrinsic variation be­
tween antibodies, these groups may exist in different locations on each. The 
same is true for carboxyl groups but there is a higher probability th a t they occur 
towards the base of the antibody Y -structure. Amine and carboxyl groups co­
valently bind to  one another. Therefore, surfaces containing these groups allow 
antibody immobilisation. Due to  their location on the antibody, the use of car­
boxyl groups increases the probability th a t antibodies will a ttach  in an upright 
position, leaving the antigen binding sites free for attachm ent (see Section 2.4.1 
for more information on antigen binding). In order for this to  occur, amine groups 
m ust be available on the immunosensor surface.
It should be noted th a t it is also possible to  cleave the arm s of the anti­
body Y -structure in order to  obtain access to  the disulphide bonds present there. 
These could then  be used to  immobilise the antibody to  the sensor surface. The 
prim ary advantage associated w ith this technique is an increased control over 
antibody orientation. However, it was decided th a t this level of optim isation 
was not required until the initial proof-of-principle sensor had been developed. 
Consequently, the immunosensor was designed to  detect antigens using whole 
antibodies rather th an  fragments.
4 .3 .2  S ilan isa tion  o f  G lass S u b stra te
The immunosensor presented in this work employed a glass microscope slide as 
the sensor substrate . This is a standard  substrate  commonly employed in optical 
chemical and biosensors. The glass slide surface consists mainly of unreactive 
silica (S i0 2), which does not readily bind amine or carboxyl groups. Therefore, 
a chemical linker was required in order to  a ttach  antibodies to  the glass surface.
Due to  the  fact th a t  they are inexpensive and easy to  use, w ith low energy 
reactions, the m ost commonly employed glass linkers are a family of chemicals 
called organosilanes [2]. These compounds, illustrated in Figure 4.4, are com­
posed of hydrolysable groups (X ), a spacing group (typically an alkyl chain) and 
an organofunctional group.
Following hydrolysis, the functional group X, typically an alkoxy or halogen, 
forms a reactive silanol group (Si-OH), which can condense w ith other silanol 
groups, for example those on the surface of glass slides, to  form siloxane link-
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Figure 4.4: Illustration of organosilane structure.
ages. The functional group F is a nonhydrolysable organic group th a t possesses 
a functionality able to react with organic species (e.g. antibodies). Thus, use of 
the organosilane results in a covalent bond between organic species and inorganic 
substrates.
For the immunosensor presented here, several silane linkers were tested, each 
with different F  functionalities such as amino (-NH2), m ercapto (-SH) and glyci- 
doxy functions. The final choice of organosilane; 3-glycidoxypropyltrimethoxysilane, 
was dictated  by the optim um  coverage and ease of implementation.
As the coverage of organosilanes on the substra te  surface is mainly depen­
dent on the density of reactive hydroxyl groups, a pre-treatm ent of the glass 
slides was carried out in order to increase the number of silanol groups present. 
This was achieved by treating the glass slides with lm o l /L - 1  sodium hydroxide 
(NaOH) solution. The substrates were then immersed in a solution containing 
the  organosilane and the m ethoxy groups of the organosilane reacted w ith the Si- 
OH groups of the glass slides to  covalently bind the organosilane to  the surface. 
This resulted in epoxyl functional groups being made available for the binding of 
organic compounds required for antibody attachm ent. The process is shown in 
Figure 4.5.
4 .3 .3  B io lin kage
A biolinkage layer was employed to a ttach  the antibodies to the functional group 
of the organosilane. Two separate biolinker layers were investigated for use w ith 
the immunosensor presented here. The first was the commonly-employed avidin- 
biotin system [3].
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Figure 4.5: Schematic of covalent binding of organosilane to glass surface. 
A vid in -B iotin  System
Avidin is a  protein th a t is present in egg whites. Biotin is a  vitam in of the B 
complex, which are a group of water-soluble vitam ins th a t include riboflavin, folic 
acid and vitam in B 1 2 . The m ajor distinguishing feature of these two molecules is 
the extremely high affinity they  have for each other (Ka =  101 5 M -1). To put this 
in perspective, it should be noted th a t  a K n value of >  107 M - 1  typically denotes 
antibodies w ith high affinity. The affinity of biotin for avidin is several orders of 
m agnitude higher th an  this. Avidin also has four binding sites for biotin, which 
increases the  num ber of possible reactions, configurations and applications of the 
avidin-biotin system.
The high affinity was exploited in the immunosensor presented here by a t­
taching biotin to  the  capture antibodies (what is known as biotinylation) and 
attaching avidin to  the  silanised surface of the glass slide. W hen the biotinylated 
antibodies were passed over the surface they attached to  the avidin molecules and 
became bound to  the  substrate.
P rote in  A
Though the  avidin-biotin system  successfully bound the capture antibodies, the 
procedure was quite lengthy and complicated. Therefore, an alternative m ethod 
was investigated. A single biolinker molecule, P rotein A, was used to  bind the 
capture antibodies to  the functional group of the  silane. P rotein A is a  protein
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produced by staph  bacteria, which live harmlessly on the skin surface. I t  displays 
a  strong affinity for the Fc portion of the  IgG antibody.
The covalent a ttachm ent of P rotein  A to  the epoxy term inus of the silane, 
3-glycidoxypropyltrimethoxysilane, occurs via its amine and carboxyl functional 
groups. The mechanisms of these two reactions axe shown in Figure 4.6.
E poxy G roup
Gamma-glycidoxypropyltn'methoxy silane immobilised on glass substrate
Protein A  a ttachm ent via carboxvl group:
CH,
HC CH, +  R— C '
O
,0
OH
CH,
r
OH
 CH2— o —
Protein A attachm ent via am ino group:
CH,
°  HC CH, +  R— NH,
Y HO
CH CH— O N R
H
Figure 4 .6: Mechanisms of covalent attachment of Protein A to organosilane.
The use of P rotein A in place of the  avidin-biotin system  provided several 
advantages. The P ro tein  A procedure required shorter preparation time, used less 
hazardous chemicals and required no p retreatm ent of the antibody. An added 
advantage of employing P ro tein  A was th a t its binding reaction is reversible, 
which allows the  same immunosensor platform  to be used repeatedly if required.
4 .3 .4  N o n -S p ec ific  B in d in g
Immunosensors are based on the specific recognition of an antibody for its antigen. 
A problem  inherent in immunosensors is non-specific binding, which can occur
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in several different forms. Sources of non-specific binding include the binding of 
antigens to  the substra te  ra ther than  to  their antibodies, labelled antibodies bind­
ing to  the substrate  rather th an  to  the antigens and capture antibodies binding 
molecules other than  the antigen of interest. Strategies to  prevent non-specific 
binding m ust be implemented.
Four non-specific binding preventative measures were employed in the work 
presented here. Two were implem ented during the antibody preparation stages 
(measures 1 and 4 listed below) and two were implem ented during the assay 
stages (measures 2 and 3):
1 . Antibodies were affinity-purified, which increased their sensitivity and re­
duced the  chance of them  binding to molecules other than  the antigen of 
interest.
2. C apture antibodies, labelled antibodies and antigens were all spatially sep­
arated  on the substra te  surface. Their channels crossed paths a t a single 
location. This m eant th a t only sensor responses from this position could 
be a ttribu ted  to  antigen binding.
3. A blocking step was introduced after the capture antibodies had been im­
mobilised, m eaning th a t  the antigens could bind only to  the capture anti­
bodies and the labelled antibodies could bind only to  the antigens.
4. Before being passed over the substrate, the labelled antibodies were mixed 
w ith a small quantity  of the protein used to  block the sensor surface (see 
previous point). This was to ensure th a t any antibodies specific to  the 
protein ra ther th an  the  antigen bound to  the  free proteins instead of those 
on the substra te  surface.
4.4 P attern ing
4 .4 .1  A rrayin g
An Affymetrix 417 Arraying system was employed to  pa tte rn  the capture antibod­
ies onto the sensor substrate . The Arrayer is based on pin-and-ring technology, in 
which a  m etal ring is immersed into the solution to  be spotted. W hen the ring is
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drawn out, it contains a meniscus of the solution. A pin is moved down through 
the meniscus, piercing it and retaining a droplet of the solution on its tip. W hen 
the pin is brought into contact with a surface, it deposits the solution.
The Arrayer is capable of printing spots sizes of 150 ¿¿m diam eter with a stan­
dard  deviation of 10%. Each ring pickup consumes approxim ately 1.5 ¿¿L of 
solution and it was possible to  pa tte rn  400 spots from each pickup. The Arrayer 
is also capable of printing approxim ately 4 spots per second, which facilitates 
rapid sensor production.
In the work presented here, the Arrayer was used to  prin t an array of anti­
bodies a t specific locations on a glass slide th a t had been treated  as described in 
Section 4.3. Figure 4.7 shows an example of fluorescence recorded from an array 
of Cy5-labelled anti-BSA antibodies printed using the Arrayer.
Figure 4.7: Array of Cy5-labelled anti-BSA antibodies printed using the Affymetrix 
417 Arrayer. Antibodies spots sizes are approximately 150 /¿m in diameter. The 
antibodies were imaged using a Gentic Microsystems fluorescence scanner.
4 .4 .2  M icroflu id ics
Upon pattern ing  of the capture antibodies onto the  sensor substrate, the next step 
required was the in troduction of the antigens and labelled antibodies. This was 
accomplished using a flowcell fabricated from poly(dimethylsiloxane) (PDMS) 
(Dow Corning). PDM S is a  silicone rubber formed from liquid prepolymer and 
curing agent. The two are mixed together and cast against an appropriate m aster. 
The PDM S is then  cured a t an elevated tem perature in order to facilitate cross- 
linking. Following curing, the  resultant PDMS m ould is peeled from the m aster. 
The concept is illustrated  in Figure 4.8.
In the work presented here, the liquid prepolym er was cast against an alu­
minium m aster containing two ridges (1 mm x 2  mm x 8  mm), with upright cap-
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Master comprised 
of 2 ridges
(a) (b )
PDMS cast against 
master and cured at 
an elevated temperature
PDMS peeled 
from master
(c) (d)
PDMS (containing 
two channels) brought 
Into conformai contact 
with substrate
Figure 4.8: Illustration of the fabrication of a PDM S flowcell. PDM S is cast against 
a channel master and cured at an elevated temperature. The resultant mould is 
peeled from the master and brought into conformai contact with the substrate, 
where it seals and acts as a flowcell.
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illary tubes positioned a t each end. It was then  cured a t 70°C for 1 hour. Upon 
solidification, the PDMS m ould was peeled from the m aster, with the resultant 
mould containing recessed channels of identical dimensions to  the ridges of the 
m aster. The mould was brought into contact w ith the sensor surface to form 
a seal and act as a flowcell.
In order to  provide tubing support, capillary tubes were inserted into the 
inlets and outlets of the flowcell, which were formed from the capillary tubes of 
the m aster. Tubing was connected to  these tubes and a peristaltic pum p was 
used to  flow solutions through the channels.
Having established the viability of the initial flow system, the dimensions of 
the channels were decreased in order to reduce the volume of solution required 
to fill them . The alum inium  m aster was replaced by one formed from SU- 8  
photoresist (Microchem, U.S.A.). SU- 8  is a negative tone photoresist. W hen 
exposed to light of an apropriate wavelength, these exposed areas become resistant 
to  chemical etching. Consequently, it is often employed in the production of 
tem plates as its unexposed areas can be removed, resulting in the formation of 
pa tterned  coatings on the  substrate.
The pa tte rn  formed on the surface is determ ined by the photom ask employed. 
By blocking light from reaching certain areas of the photoresist and allowing 
others to be exposed, the p a tte rn  formed on the surface takes the form of the 
photomask.
In the work presented here, high resolution printing was employed to  fabricate 
the  photomask. The required design was produced using CAD software and 
printed onto acetate using high-resolution printing.
A portion of a silicon wafer was coated with SU- 8  photoresist via the technique 
of spin-coating [4], UV radiation, passed through the photomask, initialised cross- 
linking of the  exposed areas of the SU- 8  film. A therm al curing step, referred to 
as the post-bake exposure, completed the cross-linking. The uncross-linked (i.e. 
unexposed) areas were then  removed through the use of the relevant solvent, leav­
ing a positive relief pa tte rn , which took the form of the  design of the photomask. 
Here, the positive relief took the form of two ridges, w ith their height determined 
by the thickness of the  SU- 8  film. The ridge dimensions were 3 mm x 200 fim  x 
440 fj,m.
PDMS was moulded against the SU- 8  m aster and cured. Once cured, the
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flowcell was peeled from the m aster and the  end of each channel was pierced 
with a needle to  form the inlets and outlets. The flowcell was then  brought into 
conformal contact with the surface of the sensor substrate. Tubing was attached 
to  the end of each needle and a peristaltic pum p was used to pass the antigen and 
labelled antibody solutions over the sensor surface.
4 .4 .3  M eth o d o lo g y
The flowcell was employed to  introduce the antibody and antigen solutions to  the 
surface of the sensor substra te  and to  provide spatial resolution. This m eant th a t 
the signal due to  antigen binding could be discrim inated from certain non-specific 
binding events.
The flowcell was positioned on the surface of the substrate  so as to  include 
the immobilised capture antibodies w ithin its channels (see Figure 4.9 (b)). Anti­
gens were introduced into one of the flowcell channels and a PBS buffer solution 
was introduced into the second channel. Upon completion of binding, PBS Tween 
was passed through the  channels to  remove unbound antigens. PBS was then 
passed through the channels to  remove all traces of PBS Tween.
The flowcell was then  removed and a second was positioned on the slide at 
right angles to  the previous flowcell (as shown in Figure 4.9 (c)). Labelled anti­
bodies were introduced into both  channels and bound to  the immobilised antigens. 
After binding had occurred, the two washing steps of PBS Tween and PBS were 
carried out.
The natu re  of the  pattern ing  resulted in the formation of the three layers 
necessary for the  sandwich assay a t only one location on the chip. This point is 
indicated as B in Figure 4.9. Consequently, it is the fluorescence recorded solely 
a t this point th a t is related to  sensor response. Point A indicates an area on 
the chip where only capture and labelled antibodies are present. Therefore, the 
fluorescence recorded due to  non-specific binding at this point serves as a back­
ground signal. This signal level is subtracted  from the sensor signal level recorded 
at point B, yielding the final antigen dependent reading.
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AntiBSA antibodies
(a)
Into one channelof flowcell
X
X
(b)
(c)
/
Labelled antibodies 
introduced into both channels 
of second flowcell
(d)
Figure 4.9: Illustration of the patterning o f each layer of the antibody sandwich as­
say. Antibodies immobilised on substrate (image (a )). Image (b) shows the position 
of first flowcell, with buffer passed through the first channel and antigen through the 
second. Image (c) shows the position of the second flowcell, with labelled antibod­
ies passed through both channels. Image (d) illustrates the combined result of all 
three layers, with no fluorescence detected at position A but fluorescence detected 
at position B, indicating the presence of antigens in the sample solution.
72
4-5. Experimental and Analysis Systems H. M. McEvoy
4.5 E xperim ental and A nalysis System s
4 .5 .1  E x c ita tio n
It is clear from the previous section th a t the presence of the antigen is indicated 
by fluorescence a t a particular point on the chip. It is, however, necessary to  en­
sure efficient excitation of the fluorophore in order to  obtain a  fluorescence signal. 
In the  immunosensor presented here, evanescent wave excitation was employed, 
m aking the sensing process surface-specific in nature  (see Section 3.4.3 for a de­
tailed explanation of evanescent wave excitation). This means th a t only those 
fluorophores bound to  the sensor substra te  (via antibody-antigen interactions) are 
optically excited, thereby elim inating the possibility of fluorescence excitation in 
the bulk solution.
O ptical excitation was provided by a 635 nm  laser diode. A laser diode was 
chosen due to  its reduced size and power consumption compared to a conventional 
Helium-Neon laser. This was im portant in the context of ultim ately producing 
a portable sensor. The wavelength of the laser diode was chosen to  overlap with 
the absorption m aximum  of the Cy5 dye in order to achieve efficient excitation 
(see Section 3.3 for more inform ation on Cy5 dye).
A line generator was attached to  the ou tpu t of the laser diode. This converted 
the circular profile of em itted light into a rectangular profile, which facilitated 
uniform illum ination (and therefore excitation) of the sensor substrate. A pa t­
terned glass slide acted as the waveguide and a cylindrical lens was employed in 
order to  focus the excitation beam  sufficiently for coupling into the  waveguide 
via its endface, as was discussed in Section 3.4.4. A schematic of the excitation 
setup is shown in Figure 4.10.
4 .5 .2  D e te c tio n
The fluorescence em itted by the  labelled-antibodies was recorded using a Charge 
Coupled Device (CCD) Cam era-based detection system. A schematic of the de­
tection system  is shown in Figure 4.11.
Cy5 dye has a fluorescence m aximum  a t 670 nm. Therefore, in order to  remove 
any excitation light, the em itted  light was passed through a 670 nm  bandpass filter 
before being collected by the CCD camera.
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Cylindrical
Lens
Laser Light
Fluorescents pots
/ Laser Diode with Line Generator
Glass Slide
Figure 4.10: Schematic of fluorescence excitation setup
FluorescentSpots
Figure 4.11: Schematic o f immunosensor fluorescence detection system.
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A graded index (GRIN) lens array was then employed to  focus the light onto 
the CCD array. GRIN lens arrays are composed of an array of rod lenses, w ith the 
refractive index of each rod lens varying in a parabolic fashion along its length. 
This results in the redirection of light passing through the  lens. The propagation 
paths in such lenses are illustrated in Fig. 4.12.
Figure 4 .12 : Illustration of light path through graded index (GRIN) lens.
By m anufacturing these lenses to  the correct length, light can be smoothly 
redirected to  a specific point of focus. The GRIN lens employed here was m an­
ufactured to  have an  effective focal length of 8.89 mm. The GRIN lens created 
a 1:1, non-inverted image of the 2D surface of the  substrate  and as it was small, 
w ith a short effective focal length, it facilitated the m iniaturisation of the setup.
The GRIN lens focused the em itted fluorescence onto the CCD array of a 
cooled CCD cam era (Sensicam PCO ) positioned a t the effective focal length of 
the GRIN lens array. As the cam era was cooled, its internal noise was kept to  a 
minimum, thus increasing its detection capability. This was an im portan t consid­
eration due to  the low light levels em itted by small concentrations of fluorescently- 
labelled antibodies (see Section 3.5 for a detailed explanation of CCD cameras). 
A nother reason for employing a  cooled CCD cam era is the  fact th a t  it is capable 
of recording 2D images. This makes it possible to  analyse several areas of the 
substra te  surface simultaneously, thus facilitating m ultianalyte sensing.
4 .5 .3  Im age A n a lysis
In order to  determ ine the presence and concentration of antigens bound to  the 
sensor substrate , the  fluorescence intensity a t two specific locations was required. 
The first occurred where the capture antibodies and labelled antibodies were 
present. The fluorescence intensity recorded a t this location was subtracted  from 
the  fluorescence intensity recorded a t the location where the capture antibodies, 
antigens and labelled antibodies were present. The difference in fluorescence
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intensity between the two recorded images was a ttribu ted  to  the presence of the 
antigen.
In order to  ex tract fluorescence intensity values from the recorded images and 
correlate them  w ith antigen concentration, the image analysis software had to 
fulfill several requirements:
1. D eterm ination of pixel intensity values.
2. Integration across defined areas in order to  determ ine m ean intensity values.
3. Background subtraction.
4. Norm alisation against maximum value.
5. Com parison of m ean intensity values.
Several commercial image analysis and modification software packages were 
investigated for suitability. These included Paint Shop Pro, Image Magic and 
IP Lab. The process th a t was finally selected involved using a custom -w ritten 
C program, the m ajority  of which was w ritten  by a colleague. The program  
converted the images to  d a ta  files, which were then plotted  and analysed using 
a second custom -w ritten program , kindly supplied by another colleague. The 
Visual Basic front panel of this program  is shown in Figure 4.13.
4.6 Sensor Perform ance
4 .6 .1  V a lid a tion  A ssay
Bovine serum album in (BSA) and its associated antibody were chosen as the 
model system  to  validate the operation of the immunosensor. Polyclonal anti- 
BSA antibodies were purified and divided into two aliquots, one of which was 
labelled w ith Cy5 dye. A glass microscope slide was cleaned (using an acid 
wash), silanised and coated w ith Protein A. Using the Aflymetrix Arrayer (see 
Section 4.4.1), an array of anti-BSA antibodies was then printed on the glass 
slide and the surface was blocked with Milk Marvel. Applying the methodology 
described in Section 4.4.3, a  PDMS flowcell was used to  pa tte rn  BSA, followed by 
labelled anti-BSA antibodies onto the glass substrate. The bound antibodies were
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Figure 4.13: Visual Basic front panel of image analysis program.
excited and detected using the systems described in  Sections 4.5.1 and 4.5.2. 
T he resultant image, w ith the position of the  control solution, BSA and labelled- 
antiBSA antibodies indicated, is shown in Figure 4.14.
4 .6 .2  D o se  R esp o n se  C urve
A full dose response curve was carried out in order to  investigate sensor perfor­
mance. A range of BSA concentrations was prepared and assays were carried 
out, as described in Section 4.6.1, w ith a different concentration of BSA being 
immobilised in each case. A single intensity value was determ ined by calculating 
the  intensity w ithin a  fixed area (the section of the channel th a t intersected w ith 
the capture antibodies, Area B in Figure 4.14). Three replicates were carried out 
for each concentration of BSA (i.e. the  assay was repeated three times for each 
concentration of B SA ). M ean intensities values were calculated and used to  de­
term ine standard  deviations for each concentration. The resultant dose response 
curve is shown in Figure 4.15.
As expected, as the  concentration of antigen decreased, the level of fluores­
cence decreased. A working range of greater th an  100,000 ng /m l of antigen to 
100ng/m l was a tta ined . Though antibodies vary in their sensitivity to  differ­
ent concentrations of antigens, the range obtained here is comparable to  those
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Figure 4.14: Image of fluorescence emitted from labelled anti-BSA antibodies, 
indicating presence of antigen (BSA) at point B. No fluorescence was detected at 
point A, as no BSA was present.
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Figure 4.15: Dose response curve for BSA/anti-BSA assay, obtained using planar 
im mu nosensor.
78
4-7. Conclusions H. M. McEvoy
achieved by similar immunosensors [5,6].
The d a ta  was fitted  into a sigmoidal four-param eter logistic equation, with 
R 2 =  0.99719 [5]. The m inimal detectable signal (MDS) was calculated from the 
m ean zero response plus 3cr (where o  represents the standard  deviation) of the 
response a t this level. The m ean zero response is the  intensity value recorded 
when no antigen is present. W ith  this system, an MDS of 137 was calculated, 
which corresponded to  a lim it of detection for BSA of approxim ately 150ng/m l.
As the three lowest BSA concentrations all lie w ithin the MDS it was not 
possible to  determ ine if the lim it of detection was due to  the sensitivity of the 
antibodies employed or due to  the MDS of the system. In order to  determine 
this, an enhanced system, w ith a lower MDS would be required.
4.7  C onclusions
This chapter described each of the techniques and systems th a t were successfully 
developed and combined in order to  produce an effective immunosensor. Devel­
opm ent of five m ain areas was required for the fabrication of the immunosensor, 
namely antibody preparation; immobilisation; patterning; experim ental and anal­
ysis systems; and validation.
Each of the steps involved in the antibody preparation, including purification 
and labelling, were described in detail in this chapter. Imm obilisation strategies 
and m ethods were discussed, w ith reference to  the functional groups available 
on the antibodies and the chemical linkers employed to  immobilise them  on the 
substrate . The pattern ing  techniques investigated were then discussed and the 
methodology explained.
A description was given of the excitation, detection and analysis systems 
developed and optim ised in order for the immunosensor to  function effectively. 
T he separate components employed were detailed, along with explanations of 
their functions.
Finally, the results from the validation assay and dose response curve obtained 
were presented. These results were comparable to  similar immunosensors detailed 
elsewhere.
The planar immunosensor developed here served to  validate the experimental 
techniques involved in the production of an optical immunosensor. The next stage
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of th is work was the progression to  an enhanced optical biochip, the development 
of which is described in the following chapters.
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Chapter 5
Enhancem ent Strategies for 
Fluorescence-Based Sensors
5.1 Introduction
Efficient capture of fluorescence emission is an im portant factor in the  perfor­
m ance of fluorescence-based biosensors. Higher levels of fluorescence increase the 
signal-to-noise ratio, which improves the sensor resolution. M ethods of dram ati­
cally increasing the  efficiency of fluorescence capture were predicted by the results 
of a theoretical analysis published previously [1]. The analysis examined the an­
gular distribution of fluorescence emission from a fluorescent molecule on or near 
a  surface. It was shown th a t, in such configurations, the fluorescence emission is 
anisotropic and th a t a  considerable portion of the emission is em itted a t angles 
th a t  result in the light being confined w ithin the substrate, w ith only a small 
fraction being transm itted  through the substrate  or into the environment above 
for detection.
Detailed analysis of these findings suggested two im portant research direc­
tions th a t im pacted strongly on this work. The first was th a t redirection of the 
substrate-confined emission out of the substrate  and towards the detector should 
result in a  significant increase in the quantity  of fluorescence captured. The 
second finding was th a t fluorescence from different positions is observed within 
different angular ranges. Therefore, via analysis of the fluorescence angular pro­
file, it should be possible to  distinguish between fluorescence from the  surface and
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th a t  from the bulk solution.
Both of these predictions have im portan t implications for fluorescence-based 
chemical sensors and biosensors. The significant increase in fluorescence capture 
efficiency would result in substantially lower limits of detection. The capability to 
distinguish between surface and bulk fluorescence would eliminate the  necessity 
of removing a fluorescing bulk solution prior to  detection. This would result in 
less complicated microfluidics and fewer steps in the assay, resulting in shorter 
m easurem ent tim e and a simpler operational protocol. Another significant ad­
vantage of the ability to  discrim inate between surface and bulk fluorescence is the 
possibility of employing direct excitation (through the bulk solution). This would 
elim inate the need for the complicated optics associated w ith surface specific ex­
citation, facilitating the  production of simpler, more robust, portable sensors.
This chapter details the experim ental verification of these two predictions, 
specifically
1. T h a t the redirection of substrate-confined emission results in enhanced flu­
orescence capture efficiency, and
2. T h a t it is possible to  discrim inate between fluorescence originating from, the 
surface and fluorescence originating from the bulk solution comprising the 
environment.
5.2 V erification of Enhanced Fluorescence Capture
5 .2 .1  A n gu lar  D istr ib u tio n  o f  F lu orescen ce  E m ission
Work published previously in this laboratory showed th a t the angular distribu­
tion of fluorescence of a radiating dipole a t a surface is highly anisotropic [1], The 
resultant angular distributions are shown in Figures 5.1, 5.2 and 5.3, w ith the su­
perscripts “1” , “s” , “a” and “w” corresponding to  layer, substrate, air and water 
respectively. Figures 5.1 and 5.2 correspond to  polar representations of the angu­
lar distribution and Figure 5.3 corresponds to  a cartesian representation. In each 
case, the substra te  employed in the model is glass, with Figure 5.1 corresponding 
to  an air environm ent and Figure 5.2 corresponding to  a water environment.
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Air
Glass Substrate Fluorescent
Figure 5.1: Angular distribution of fluorescence intensity radiated by a fluorescent 
spot situated on a glass substrate, which is surrounded by air.
Water
Glass Substrate Fluorescent
Figure 5.2: Angular distribution of fluorescence intensity radiated by a fluores­
cent spot situated on a glass substrate. The superstrate corresponds to a water 
environment.
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0 (deg)
Figure 5.3: Cartesian representation of the fluorescence angular distributions. The 
solid and dashed lines correspond to the distributions in air and water environments, 
respectively, with 6“s corresponding to the critical angle of the air/glass interface 
and QcS corresponding to the critical angle of the water/glass interface. The in­
tensities radiated into intervals 6 G (0 ° ,9 0 ° )  and 6 G (90 °, 180°) correspond to 
radiation into the substrate and environment, respectively.
Using these angular profiles, the fluorescence emission can be divided into 
four categories. The first category refers to  the fluorescence em itted into the 
environment above the  substra te  (air in Figure 5.1 and water in Figure 5.2) 
and, for the purposes of this discussion, will be referred to  as A T /W T  (air- 
transm itted  or w ater-transm itted). The second category refers to the fluorescence 
transm itted  through the  substra te  into the environment below. This fluorescence 
occurs a t angles 8 e  (—8™, 8“s), where, as sta ted  previously, the superscripts “a” 
and “s” represent the  air and substrate  respectively. The angle of fluorescence 
emission is represented by 8 and the relevant critical angle by 8C (i.e. 0 “s is the 
critical angle of the a ir /su b stra te  interface). This fluorescence will be referred 
to  as substrate  transm itted  (ST) fluorescence. The th ird  category is th a t of the 
substrate-confined (SC) fluorescence. This fluorescence occurs a t angles of 8 6  
(0 e«,0 is) an(j q g (—8^s, —6lcs), where “e” and “1” represent the environment and 
fluorescent layer, respectively and all other symbols are as previously described. 
As predicted by the  name, this fluorescence is trapped  within the substrate. The 
fourth and final category is th a t of evanescent wave (EW ) fluorescence and occurs 
a t angles of 8 G 90°) and 8 6 {—8lcs, 90°), where “1” represents the fluorescent 
layer or spot and all o ther symbols are as previously described. EW  fluorescence
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is also confined w ithin the substrate  but unlike SC fluorescence, it results in an 
evanescent field in the fluorescent layer/spot deposited on the surface.
In the m ajority  of fluorescence-based sensors, detection occurs either directly 
above or directly below the fluorescent spot, which corresponds to  detection of the 
A T /W T  or ST fluorescence. From Figures 5.1, 5.2 and 5.3, it can be seen th a t 
this fluorescence corresponds to  only a small fraction of the to ta l em itted fluores­
cence. This implies th a t these configurations do not provide efficient fluorescence 
capture.
The SC fluorescence comprises as much as 6 6 % of the to ta l em itted fluores­
cence. This SC fluorescence is also confined to  relatively narrow angular ranges, 
w ith A d = 8lcs — 6™ 30° and AO = 8lcs — 6™s «  10°. Therefore, enhancement
of the overall fluorescence capture efficiency was focused on the m anipulation of 
this SC fluorescence. Redirection of the  SC fluorescence, out of the substra te  and 
onto a detector positioned beneath, should result in a significant enhancem ent in 
the quantity  of fluorescence recorded.
The following sections detail the design, fabrication and performance of a custom- 
designed structure  employed to  redirect the SC fluorescence out of the substrate 
and onto a detector, thereby increasing the fluorescence capture efficiency.
5.2 .2  D esig n  o f  E n h an cem en t S tru ctu re
In order to redirect the SC fluorescence, the top surface of a planar substrate  was 
modified to incorporate a frustrated  cone [2 ]. A cross section of the structure is 
shown in Figure 5.4.
The enhanced structure  is based on the principle th a t SC fluorescence em itted 
from a fluorescent spot deposited on the top of the frustrated cone is totally 
internally reflected by the tilted  interface (A in Figure 5.4). Careful choice of the 
angle a  ensures this occurs. Using basic geometry, it can be shown th a t
w
t a n a  =  ta n #  — — (5.1)
where w represents the  w idth of the top  of the frustrated  cone and h is the height 
of the frustra ted  cone.
An added advantage of the to ta l internal reflection of the SC fluorescence by 
the tilted  interface, A, is th a t the reflected fluorescence impinges on the bottom
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I"
Figure 5.4: Cross section of structure employed to improve fluorescence capture 
efficiency. The frustrated cone facilitates the redirection of the SC fluorescence out 
of the substrate onto the detector positioned below.
surface a t angles close to  0 °, resulting in the m ajority  of the fluorescence being 
transm itted  out of the substrate  onto the detector.
5 .2 .3  F ab rication  o f  E n h an cem en t S tru ctu re
Polymers were chosen as the  m aterials for the new enhanced substrate  due to  the 
fact th a t they are a  versatile range of m aterials th a t can be moulded and machined 
w ith relative ease. Surface properties can be modified to  suit various applications 
(e.g. to increase hydrophobicity or to  facilitate binding of molecules). Optically 
transparent polymers are readily available, which was an im portant factor in the 
application presented here.
Using a commercially available CA D/CA M  software package (XCAD, X-NC, 
U.K.), a chip design, incorporating six frustrated  cones on its surface was pro­
duced. Using this design in conjunction w ith high-precision Com puter Numeri­
cally Controlled (CNC) micromilling and spark-erosion, a brass mould of the  de­
sired chip was fabricated by Parsec (Dublin). Polym ethyl m ethacrylate (PMMA) 
structured chips were then produced using a Babyplast micro-injection moulder 
(JE T  Industrial Services, U.K.). The brass mould employed and the resultant 
structured  polymer chips are shown in Figure 5.5.
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Figure 5.5: Brass mould and resulting custom-designed chip containing six frus­
trated cones.
5 .2 .4  E x p er im en ta l M eth o d
In order to  verify the  improved fluorescence capture provided by the structured 
chips, fluorescent m aterial was deposited onto the  frustrated  cones and onto a pla­
nar substrate  and the  quantity  of fluorescence collected from the two locations 
was compared.
The ruthenium  complex ruthenium (II) tris(4,7-diphenyl-l,10-phenanthroline), 
(Ru(dpp ) 3 2+), was employed as the fluorescence source for all experimental work 
described in this chapter. This is a commonly employed dye with a large quan­
tum  efficiency ( «  0.35) and Stokes’ Shift. Its excitation and emission maximum 
occur a t 460 nm  and 605 nm  respectively, as shown in Figure 5.6.
The large Stokes’ Shift associated w ith this dye complex ensures th a t  interfer­
ence from excitation light is kept to  a minimum . In the  work presented here, the 
ruthenium  dye complex was either dissolved in solution or entrapped in a porous 
sol-gel layer.
The sol-gel process involves the use of m etal organic precursors to  form glass 
a t low-tem perature. The precursors in liquid “sol” phase polymerise to  form a gel. 
Further polymerisation, hydrolysis and heat treatm ents result in the formation 
of glass (due to  the elim ination of water from the system). Addition of the dye 
complex during the  sol phase results in inclusion of the  dye molecules w ithin the 
glass structure. Thus, the sol-gel acts as a m atrix  for the dye. For the following 
sections, the term  “doped sol-gel” shall be used to  refer to  sol-gel doped with 
Ru(dpp)3 2+.
Using a Genomics P in-P rin ter, a spot (approximately 5 /¿m thick) of doped
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Figure 5.6: Graph of absorption and emission spectrum of the ruthenium dye 
complex ruthenium(ll) tris(4,7-diphenyl-l,10-phenanthroline), (Ru(dpp)3 2+). Also 
shown is the emission spectrum of the blue LED used to excite the ruthenium dye 
complex.
sol-gel was printed on the upper surface of each of the frustrated  cones of the 
structured  chip and also as discrete spots on the planar portion of the chip (see 
Section 6.3 for an explanation of the printing process). A blue LED (A=460nm) 
was used to  excite the  dye (emission spectra shown in Figure 5.6) and the resultant 
fluorescence was em itted  into the environment and substrate  as illustrated in 
Figure 5.1. Fluorescence transm itted  through the chip was collected by a cooled 
CCD camera, positioned behind the chip.
5 .2 .5  Im age A n a ly sis
The 2D images recorded by the  CCD cam era were analysed using a M athem atica 
program  (based on C) th a t was w ritten  in-house. This program  correlated pixel 
values w ith fluorescence intensity. The intensity of fluorescence recorded from 
a defined area was calculated by integrating the pixel values over this area.
In order to  determ ine the level of enhancement provided by the frustrated 
cones, the  quantity  of fluorescence em itted from a  spot of doped sol-gel printed 
on the top of such a cone was compared with the  quantity  of the fluorescence 
em itted  from a spot of doped sol-gel deposited on the planar portion of the chip.
89
5.2. Verification o f Enhanced Fluorescence Capture H. M. McEvoy
It should be noted tha t, using a structured chip coated w ith undoped sol-gel, 
a  background intensity reading of zero was recorded and was used els a background 
signal to  sub tract from all other m easured values. Therefore, the  numerical results 
presented in the following section were unaffected by background intensity.
5 .2 .6  R esu lts
A typical example of an image of the  fluorescence recorded from a printed struc­
tu red  chip is shown in Figure 5.7.
Figure 5.7: A representative image of the fluorescence intensity recorded from 
an enhancement chip. The ring and spot on the left-hand-side of the image cor­
responds to the fluorescence recorded from doped sol-gel printed on the top of 
a frustrated cone. The spot on the right-hand-side of the image corresponds to the 
fluorescence recorded from doped sol-gel printed on the planar portion of the chip.
Two distinct fluorescence profiles are evident. The ring-like profile (together 
w ith the central spot) on the left-hand-side of the image corresponds to  the 
fluorescence em itted from the  doped sol-gel spot printed on the upper surface 
of a frustra ted  cone. The ring (R l) corresponds to  the SC fluorescence and 
the spot in the centre of the ring (C l) corresponds to  the  ST fluorescence (see 
Section 5.2.1 for explanation of SC and ST fluorescence). The spot on the right- 
hand-side of the image (P I)  corresponds to  the ST fluorescence em itted from the 
doped sol-gel printed on the  planar portion of the chip, i.e., corresponding to  the 
detection configuration employed by a wide range of fluorescence-based scanners.
A circular area, centred on C l and including R l, was selected and the to ta l 
intensity in this area was calculated. An identical circular area, centred on P I , 
was then  selected and the to ta l intensity w ithin this area was obtained. The ratio
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of these two intensities was then  calculated. In the case of Figure 5.7, a ratio, 
or enhancem ent factor, of 39 was achieved. Employing the same excitation and 
detection in each case, 15 printed enhancem ent chips were excited and analysed. 
A m ean enhancem ent factor of 35 ±  5 was achieved, resulting in, on average, 
35 tim es more fluorescence detected from the frustrated  cones compared to the 
p lanar portion of the chip.
5 .2 .7  Su m m ary
The theoretical analysis discussed in Section 5.1 postulated  th a t the redirection 
of the SC fluorescence em itted  by fluorescent m aterial on a surface should result 
in enhancem ent of the fluorescence capture efficiency. In order to  verify this, 
a custom-designed structured  chip, employing redirection elements was fabricated 
and printed w ith fluorescent m aterial. The printed chip was excited and the 
resultant fluorescence images analysed. The use of the enhanced configuration 
resulted in a significant increase in fluorescence capture efficiency when compared 
with a conventional planar platform , thereby verifying the first prediction of the 
theoretical analysis.
5.3 D iscrim ination  o f Surface Versus Bulk Flu­
orescence
The second prediction of the theoretical analysis discussed in Section 5.1 was 
th a t it should be possible to  distinguish between fluorescence originating from 
the surface and the fluorescence originating from the bulk solution comprising 
the environment. The following sections describe the design and experimental 
verification of this prediction.
5.3 .1  A n gu lar  D istr ib u tio n  o f  F lu orescen ce  C on trib u tion  
from  B u lk  and  Surface
To determ ine the angular d istribution of fluorescence originating a t a surface 
compared to  th a t from a bulk solution, a multilayer system  comprised of a sol- 
gel-coated glass substra te  covered by a bulk solution was modelled (schematic
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shown in Figure 5.8) [2],
Bulk __ *
Solution
Sol-ge!__
Layer
Glass ►
Substrate
Figure 5.8: Schematic of multilayer system, consisting of a glass substrate, sol-gel
layer and bulk layer.
The resultant theoretical angular distributions of the fluorescence intensity 
are shown in Figures 5.9 and 5.10. Figure 5.9 (a) corresponds to  the  situation 
where the bulk layer contains fluorescent molecules but the sol-gel layer does not, 
while Figure 5.9 (b) corresponds to  the  situation where the sol-gel layer contains 
fluorescent molecules but the bulk layer does not. Figure 5.10 corresponds to  the 
situation  where bo th  the sol-gel and the bulk layers contain fluorescent molecules. 
In all cases, the refractive index of the bulk layer is nb =  1.33 and its thickness 
is denoted by while the refractive index and thickness of the sol-gel layer 
are n L =  1.43 and ti =  1.5 A, respectively (where A represents the excitation 
wavelength).
From Figures 5.9 and 5.10, it can be seen th a t the  theoretical analysis predicts 
th a t the  contribution originating from the sol-gel layer and the bulk layer are 
observed w ithin different angular regions. In particular, the m ain contribution 
originating from the  bulk layer is radiated  a t angles below the  critical angle Q™s 
(where 9™s corresponds to  the critical angle of the w ater/glass interface), while 
the  m ain contribution originating from the th in  sol-gel layer is observed a t angles 
above the critical angle 6™s.
5 .3 .2  E x p er im en ta l S etu p
In order to  verily the theoretical predictions summ arised in Section 5.1, an ex­
perim ental analysis of custom ised samples was carried out. Sol-gel layers were 
formed on glass slides by dip-coating, a process which involves the immersion 
and withdrawal of the slides from a sol. The thickness of the layer increases with 
the  ra te  of removal. As was the  case in Section 5.2, the ruthenium  dye complex
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(a) (b)
Figure 5 .9: Angular distributions of fluorescence intensity emitted from a multilayer 
system in which a glass substrate is coated with a sol-gel layer and covered by a 
bulk layer. Graph (a) corresponds to the situation where the bulk layer contains 
fluorescent molecules but the sol-gel layer does not and graph (b) corresponds to 
the situation where the sol-gel layer contains fluorescent molecules but the bulk 
does not.
Ru(dpp)3 2+ was employed as the fluorescent compound. Fluorescence from the 
doped sol-gel layer fulfilled the role of surface-originating fluorescence while th a t 
originating from the doped solution above the sol-gel layer was considered to be 
bulk fluorescence.
Using a refractive index m atching fluid, a sol-gel-coated slide was attached to 
a semi-cylindrical prism. Use of the semi-cylindrical prism ensured th a t the an­
gular distribution of the  rad iated  fluorescence was m aintained. A poly(dimethyl- 
siloxane) (PDM S) flowcell (see Section 4.4.2 for more information on PDMS) 
was sealed against the glass slide and a  peristaltic pum p was used to  flow bulk 
solutions across the slide. The setup is shown in Figure 5.11.
The bulk solutions employed were ethanol and Ru(dpp)3 2+-doped ethanol, 
corresponding to  non-fluorescing bulk and fluorescing bulk solutions, respectively. 
The flowcell, slide and prism  were attached to  a ro tary  stage, which facilitated the 
precise alignment and m easurem ent of the fluorescence emission angles. Fluores­
cence excitation was achieved via a  blue, fibre-coupled LED (emission spectrum  
shown in Figure 5.6). The position of the fibre tip  was adjusted so as to  provide 
a small spot of light (diam eter of «  1  mm) in the centre of the sample, which
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Figure 5.10: Angular distribution of fluorescence intensity emitted from a multilayer 
system in which a glass substrate is coated with a doped sol-gel layer and covered 
by a fluorescent bulk layer.
coincided with the  centre of the semi-cylindrical prism. Fluorescence em itted by 
the excited ruthenium  complex was transm itted  through the prism to  a  detector 
positioned at the face of the prism.
A linear detector array (LDA) was employed to  m easure the intensity and 
angle of the fluorescence emission. The LDA comprised 1024 photodiodes, po­
sitioned in a linear form at. An in-house, custom -w ritten LabVIEW  program 
controlled the ro tary  stage, d a ta  acquisition and visualisation. By plotting the 
intensity from each photodiode against its location on the LDA, a 2D m ap of the 
fluorescence emission profile was obtained, detailing the intensity em itted a t each 
angle.
5 .3 .3  E x p er im en ta l M eth o d
Two samples were investigated. The first consisted of a  glass slide coated w ith a 
doped sol-gel layer and the second consisted of a  glass slide coated w ith an un­
doped sol-gel layer. Sequences of fluorescing and non-fluorescing bulk solutions 
were passed over each of these samples and the em itted fluorescence recorded. 
The sequences are sum m arised in Table 5.1.
Following acquisition of the  fluorescence profiles corresponding to  each of the 
steps described in Table 5.1 (a), the glass slide coated with doped sol-gel was 
replaced by a glass slide coated w ith an undoped sol-gel layer. The sequence of
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Linear Detector
Figure 5 .11: Experimental setup for distinguishing between surface and bulk flu­
orescence. Radiated fluorescence originating from the bulk solution and/or the 
surface of a coated glass slide was transmitted through a prism to a linear detector 
array, which measured the intensity and angle of emission.
steps described in Table 5.1 (b) was passed over the sample and the corresponding 
fluorescence emissions recorded. The reason for the  exclusion of water from the 
sequence described in Table 5.1 (b) will be explained in Section 5.3.4.
5 .3 .4  R esu lts  
C alculation o f C ritical A ngles
The refractive indices of each of the solutions and m aterials employed are listed 
in Table 5.2. These values were used to  calculate the critical angles of each of the 
interfaces. The calculated critical angles, which were employed in the analysis of 
the experim ental results, are listed in Table 5.3.
D eterm ination  o f C alibration Functions
The linear detector array (LDA) employed to  record the angular profile of the 
fluorescence emission from each sample consisted of 1024 photodiodes, w ith the 
signal from each photodiode representing a pixel on the acquired image. Due to
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M edium Above Doped
Step Sol-Gel Layer M edium Above UnDoped
1 air Step Sol-Gel Layer
2 water 1 air
3 doped ethanol 2 ethanol
4 water 3-6 doped ethanol
5 doped ethanol 7 undoped ethanol
6 undoped ethanol
(a) (b)
Table 5.1: Sequence of steps specifying medium above sol-gel layer. The tables 
(a) and (b) correspond to the sequence of bulk solutions above the sol-gel layer for 
the doped and undoped samples respectively.
Solution/M aterial Refractive Index
air 
water 
ethanol 
sol-gel 
glass substrate
na — 1 . 0 0 0  
n w =  1.332 
n e =  1.362 
m =  1.425 
n s =  1.515
Table 5 .2: Refractive index values of each of the solutions and materials employed 
during the experiment.
the fact th a t the detector was linear and the face of the semi-cylindrical prism was 
curved, the distance between each photodiode and the prism  varied in relation to 
its position in the LDA. Therefore, it was necessary to  determine a relationship 
between the m easured intensity of a particular photodiode and the true inten­
sity a t the corresponding angular position. It was also necessary to  determine 
a relationship between the pixel num ber and the corresponding angular position.
The determ ination of these relationships was achieved via the use of a sample 
comprised of a glass slide coated with a relatively thick luminescent layer ( «  0 . 8  /¿m) 
and surrounded by air. This sample was chosen due to  the fact th a t the angular 
profile of the rad iated  luminescence contained a distinct peak, which allowed its 
angular position to  be determ ined precisely. An explanation of the angular profile 
obtained is provided by the theory referred to  in Section 5.1.
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Interface Critical Angle
air/glass substrate  
w ater/glass substrate  
ethanol/glass substrate 
sol-gel layer/glass substrate
0 "  =  41.30° 
6™ =  61.55° 
Qecs =  64.03° 
6lcs =  70.15°
Table 5 .3 : Critical angles corresponding to various interfaces.
The coated sample was attached to  the semi-cylindrical prism and m ounted on 
a ro tary  stage, as before. An LED coupled to  an optical fibre was used to  excite 
the central point of the sample and the resultant angular profile of the fluorescence 
emission was recorded using the LDA. After the image had been acquired, the 
sample, prism  and light source were ro tated  by A d =  2 ° and a second image was 
acquired. This process was repeated 9 times and the corresponding experimental 
d a ta  is shown in Figure 5.12.
In the graph, the  x  axis corresponds to  the  pixel number, i.e., the position of 
each photodiode, and the y  axis represents the corresponding intensity detected 
by th a t particular photodiode.
Pixels
Figure 5 .12: Angular profile of the fluorescence intensities obtained for 9 different 
orientations of the semi-cylindrical prism containing the sample. The angles of 
rotation are shown in the graph. Also shown are the calibration functions of the 
detection system.
The overall angular profile of the fluorescence em itted remained unchanged 
as the stage was ro tated . However, slight distortion occurred a t the edges of 
the image due to  the fact th a t the photodiodes a t the edges of the LDA were
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further from the face of the semi-cylindrical prism than  those in the centre. This 
is clearly dem onstrated by the decrease in intensity of the peak as its position 
approached the edge of the image.
The variation of the peak intensity across the image could be described by 
the following quadratic function:
y =  A  + B x  + C x 2 (5.2)
where A  =  0.6255, B  =  5.230 x 10- 4  and C =  —5.229 x 10-7 , w ith y  repre­
senting the detected luminescence intensity and x  representing the pixel position.
It was observed th a t every ro tation of the sample by A 9 =  2° corresponded 
to  the same change of the peak position on the image i.e. a linear relationship 
existed between the variation of the angular position of the peak and the sample 
rotation. Subsequently, the relationship between the difference in the angular po­
sition, represented by A [deg], and the difference in the pixel position, represented 
by A  [pxl], was calculated to  be:
A [pxl] =  27.41 A [deg] (5.3)
A [deg] =  0.03648 A [pxl] (5.4)
Equations 5.3 and 5.2 represent the calibration functions of the LDA-based 
detection system. Angular fluorescence intensity profiles obtained by the LDA
need to  be divided by the intensity calibration function 5.2 in order to  obtain
the true  intensity values. Subsequently, the profile is transform ed to  the angular 
profile using Equation 5.3.
It should be noted th a t this procedure does not provide absolute values of 
angles bu t only the relative angular differences. This is due to  the experimental 
apparatus, as the positions of the samples and semi-cylindrical prism  are not 
identical for each experiment. However, once a sample is in place and the absolute 
value of a particular pixel is determined, this value does not change over the course 
of the experiment. Therefore, in order to  interpret the da ta  obtained, the angular 
profile of the em itted  fluorescence m ust contain a t least one feature w ith a known 
angular position.
After the calibration procedure had been completed, testing of different sam­
ples could proceed.
98
5.3. D iscrim ination o f Surface Versus Bulk Fluorescence H. M. M cEvoy
D oped  Sol-G el-C oated Slide
The first sample investigated was a glass slide coated w ith a doped sol-gel layer. 
Using the setup described in Section 5.3.2, the sequence of solutions listed in 
Table 5.1 (a) was passed over the coated slide. The resultant angular profiles of 
the fluorescence intensity when the  layer was surrounded by the first and second 
solutions, i.e., air and water, are shown in Figure 5.13
(degO
Figure 5 .13: Angular distributions of the fluorescence intensity radiated by a doped 
sample surrounded by air (curve 1) and water (curve 2) The curves represent the 
stabilised profiles and they correspond to the data which was calibrated using Equa­
tions 5.3 and 5.2.
Curve 1 in Figure 5.13 corresponds to  the angular profile of the fluorescence 
intensity when the sample was covered by air. After the bulk changed from air to 
w ater, the angular profile changed to  th a t shown by curve 2. The profile matches 
well w ith the theoretical plots shown in Section 5.3.1. In particular, there is an 
obvious transition  between the almost constant intensity profile below the critical 
angle 9™s and the profile w ithin the angular range 9 G (0“ s, 9lrs), in which distinct 
peaks are present.
This feature was used to  determ ine the absolute position of the sample. From 
Table 5.3, it was deduced th a t  this feature was located at 9™s =  61.55° and all 
o ther features and their corresponding angular positions were determ ined relative 
to  th is value.
The water bulk solution was then  replaced by ethanol doped w ith Ru(dpp)3 2+- 
After a stabilisation time, during which the angular profile of the fluorescence 
intensity was unpredictable due to  the mixing of the two solutions, the profile
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shown as curve 3 in Figure 5.14 was obtained.
Figure 5.14: Angular distributions of the fluorescence intensity radiated by a doped 
soi-gel-coated glass slide. The curves correspond to the cycle during which the 
doped layer was surrounded by a doped ethanol solution (curve 3), water (curve 4) 
and the doped ethanol solution (curve 5), respectively. The curves represent the 
stabilised profiles and are calibrated using Equations 5.3 and 5.2.
A notable difference between the angular profiles in Figure 5.13 and in Fig­
ure 5.14 is the shift in position of the feature characterising the location of the 
critical angle of the  substrate/environm ent interface. Due to  the change of the 
environm ent from water to  ethanol, this feature moved from the angular posi­
tion corresponding to  Q™s to  th a t corresponding to  0ecs. Applying the calibration 
function 5.3 to  the m easured values showed th a t they were in agreement with the 
theoretical values listed in Table 5.3. Therefore, it was concluded th a t changes 
in refractive index can be observed using this experim ental m ethod.
Upon changing the bulk solution from non-fluorescing water to  fluorescing 
ethanol, the intensity of the angular profile below 0ecs increased substantially rel­
ative to  the intensity of the  profile above this angle. This is in excellent agreement 
w ith the theoretical predictions, i.e. th a t the m ajority  of the fluorescence origi­
nating from the bulk solution is observed at angles below the critical angle 6ecs.
During the  course of the  experiment, an overall decrease in the intensity of 
the  angular profile was observed, as can be seen upon comparison of the plots 
in Figure 5.13 and 5.14. One possible explanation for th is decrease may be th a t 
the fluorescent molecules in the  bulk solution absorbed a  portion of the excitation 
light (as is required in order to  generate the fluorescence). Due to  this absorption,
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the intensity of the excitation light reaching the sol-gel layer would be reduced. 
Consequently, the contribution of the sol-gel layer to  the fluorescence intensity 
would be reduced, resulting in a reduction of the intensity of the profile above 
the critical angle 0pf , as seen in Figure 5.14.
In the next step of the experiment, the doped-ethanol solution was replaced by 
water (non-fluorescing). A period of stabilisation, corresponding to  the transition 
to  a purely aqueous environment, was again observed. The stabilised angular pro­
file is represented by curve 4 in Fig. 5.14. Comparing this profile to th a t obtained 
when the layer was last in such an environment (curve 2 in Fig. 5.13), it can be 
seen th a t the angular profile of the fluorescence intensity is essentially unchanged. 
The m ost significant discrepancy is an overall decrease in intensity by a factor 
of approxim ately 2 across the  entire angular range. Variations in the intensity 
of LED emission were not thought to  be sufficient to  account for such a change. 
A possible explanation for the observed decrease in the fluorescence intensity was 
removal of ruthenium  complex molecules from the layer or their quantum  yield 
was somehow reduced during the experiment (possibly via photobleaching).
The following stage of the experiment consisted of again replacing the water 
w ith a dye-doped ethanol solution. The corresponding angular profile of the 
fluorescence intensity (shown by curve 5 in Fig. 5.14) exhibited the same features 
as the profile corresponding to  the previous identical transition discussed above. 
However, a further decrease in the overall intensity of the angular profile was also 
observed. This continued decrease supported the proposed process of leaching of 
the fluorescent molecules from the sol-gel layer
In order to  eliminate the unpredictable behaviour of the angular profile dur­
ing the transition  period between water and the doped-ethanol solution, it was 
decided to  instead employ undoped ethanol as the non-fluorescing solution. This 
elim inated possible issues associated w ith the refractive index difference between 
water and ethanol, along w ith the unpredictable mixing behaviour of the two. 
This step resulted in a sm ooth transition  between fluorescing and non-fluorescing 
solutions.
Three additional cycles of fluorescing bulk followed by non-fluorescing bulk 
were carried out. The resultant angular profiles of the fluorescence intensity 
corresponding to  these three cycles are shown by curves 1-6 in Fig. 5.15.
Com paring the curves in Figure 5.15 (a) and 5.15 (b), a clear difference in
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(a)
(b)
Figure 5 .15: Angular profiles of the fluorescence intensity radiated by the doped 
sol-gei sample. The curves correspond to the cycle during which the doped layer was 
surrounded by a doped ethanol solution— curves 1, 3 and 5 in the graph (a )— and 
by an undoped ethanol solution— curves 2, 4 and 6 in the graph (b). The curves 
represent the stabilised profiles and are calibrated using Equations 5.3 and 5.2.
the angular profiles is observed below the critical angle 9pf .  W hen the doped 
solution is present above the sol-gel layer, a significant increase in intensity is 
observed below this angle compared to  the  angular range above it. This is, 
again, in agreement w ith theoretical predictions. Therefore, this section of work 
shows th a t, in the case of the fluorescing surface (represented by the doped sol-gel 
layer), it is indeed possible to  distinguish between fluorescence contributions from 
the  bulk and the surface. The next stage of this work was to  determine if this 
discrim ination is possible in the case of a non-fluorescing surface (represented by 
an undoped sol-gel layer).
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U ndoped  Sol-G el-C oated Slide
Upon completion of the cycles employing a doped sol-gel layer, the sample was 
replaced by a glass slide coated w ith a  layer of undoped sol-gel. Figure 5.16 shows 
the angular fluorescence intensity profiles recorded for the sequence of solutions 
listed in Table 5.1 (b).
(a) (b)
Figure 5 .16: Angular profiles of fluorescence intensity from a glass slide coated with 
an undoped sol-gel layer. The numbers associated with the curves correspond to the 
steps summarised in Table 5.1 (b). The curves were calibrated using Equations 5.3 
and 5.2.
Curve 1 in Figure 5.16 corresponds to  the angular profile obtained in an air 
environm ent. According to  the theoretical analysis, as the distance between the 
radiating dipole and the surface increases, the intensity above the critical angle 
decreases [1]. In particular, for large distances, there is an abrupt decrease in 
intensity above the  critical angle. This is due to  the nature of the coupling of 
the light into the substrate . As explained in Chapter 3, the electromagnetic 
field propagating in the  glass a t angles 6 €  (0®s, 90°), extends an exponentially 
decaying tail (known as the evanescent field) into the surrounding media. The 
fluorescence detected w ithin this angular range is provided by coupling of the 
dipole’s near-field w ith the evanescent field. Consequently, for large distances 
of the dipole from the  surface, the evanescent field does not reach the dipole’s 
position. This implies tha t, due to  weak coupling of the evanescent field and the 
dipole’s near-field, very little fluorescence is detected above the critical angle for
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such large distances.
In the setup employed here, the blue excitation light originates a t a large 
distance from the surface (tip of the  optical fibre). Therefore, for the reasons ex­
plained above, it could not be coupled into the glass, implying th a t it would not 
be detected at angles greater th an  the critical angle Consequently, consider­
ing the divergence of the beam  emerging from the tip  of the fibre, the increase of 
the intensity below the angle 43°, shown in Curve 1 in Figure 5.16, was attribu ted  
to  the blue excitation light and this angle was determ ined to  correspond to  the 
critical angle
The second feature present in the angular fluorescence emission profile is 
a peak th a t is found around the angle 6\. This was a ttribu ted  to scattering 
of the blue excitation light a t either the top or bottom  interface of the sol-gel 
layer or w ithin the layer. This scattering would have effectively acted as a source 
of light w ithin the  layer, resulting in a non-zero intensity w ithin the angular 
range 0 e (9ecs,6 lcs), as observed.
In the next step of the experiment, the solution above the sample was changed 
from air to  undoped-ethanol. The corresponding angular profile of the fluores­
cence intensity is illustrated  by curve 2 in Figure 5.16. The slight increase of the 
m easured intensity below 0ecs was again a ttribu ted  to  the  blue excitation light and 
it was this distinctive feature th a t was used to  determ ine the absolute angular 
position of the sample.
Following the undoped-ethanol solution, a  doped-ethanol solution was intro­
duced above the  sample, resulting in a substantial increase in the fluorescence 
intensity below 8™, compared to  the fluorescence detected above this angular 
position. This is dem onstrated  by curves 3 and 4 in Figure 5.16 (a). Curve 3 cor­
responds to  the transition  ethanol—»fluorescent solution and curve 4 corresponds 
to  100% fluorescent solution. Once attained, this satu rated  profile remained 
constant.
W hen undoped ethanol was re-introduced above the layer, the fluorescence 
intensity decreased back to  the  level it had been a t previous to  the introduction of 
the fluorescent solution. This is dem onstrated by curves 6  and 7 in Figure 5.16 (b). 
Similar to  curve 3 in graph (a), curve 6  corresponds to  the transition fluorescent 
solution—»ethanol.
There is a  clear distinction between the angular profiles of the fluorescence
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intensity when the bulk solution was non-fluorescent (curves 2 and 7) and when 
the bulk solution was fluorescent (curves 4 and 5). Replacing the non-fluorescing 
bulk w ith a fluorescing bulk resulted in a substantial increase in intensity below 
the critical angle (9“s, compared to the effect on the  profile above this angle. Thus, 
this work successfully dem onstrated the prediction of the theoretical analysis (see 
Section 5.1) th a t it is possible to  distinguish between the fluorescence contribution 
from the  bulk and from the surface.
5 .3 .5  S u m m ary
The theoretical analysis discussed in Section 5.1 predicted th a t it should be pos­
sible to  distinguish between surface- and bulk-originating fluorescence. In order 
to experim entally verify this prediction, doped and undoped sol-gel-coated glass 
slides were fabricated and, using the setup described in Section 5.3.2, doped and 
undoped bulk solutions were passed above the samples. The resultant angular 
profiles of the rad iated  fluorescence intensities were analysed. Exam ination of 
particular angular ranges of the radiated  fluorescence intensity showed th a t it is 
possible to  discrim inate between surface and bulk fluorescence. In particular, it 
was shown th a t changing the  bulk solution from non-fluorescing to  fluorescing 
resulted in a substantial increase in the em itted fluorescence below the critical 
angle 6 bu t resulted in only a negligible effect above this angle. This was in 
agreement w ith theoretical predictions.
5.4 Surface Versus B ulk F luorescence D iscrim ­
ination  U sing E nhancem ent Structure
The custom-designed, structured chip described in Section 5.2 is based on the 
redirection of SC fluorescence out of the chip and onto a detector placed below. 
As fluorescence originating from the bulk solution is em itted a t a different range 
of angles to  the  SC fluorescence (see Section 5.3.2), surface versus bulk fluores­
cence discrim ination should be inherent in the design of the structures. The 
following sections detail the experim ental work undertaken in order to  determine 
the validity of this.
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5.4 .1  E x c ita tio n  and  D e te c t io n  S y stem s
Structured chips, each incorporating six frustrated cones, were fabricated as de­
scribed in Section 5.2.3. Non-fluorescing and fluorescing surfaces were defined 
by doped and undoped sol-gel layers, respectively, printed onto the top of the 
frustrated cones. As the frustrated cones were designed for optimum operation 
in water, the non-fluorescing and fluorescing bulks were defined by water and 
doped-water passed above the chip surface. The XCAD design used to gener­
ate the chips was updated to include a dual-channel flowcell, which, when sealed 
against the chip surface, enclosed three frustrated cones in each channel. There­
fore, using micro-injection moulding, it was possible to simultaneously produce 
chips and flowcells.
Excitation of the ruthenium dye complex was achieved via a blue LED (emis­
sion spectrum shown in Figure 5.6). A schematic of the excitation and detection 
set-up is shown in Figure 5.17.
From Pump
To Pump
Figure 5.17: A schematic of the excitation and detection system employed to 
determine if the capability to discriminate between surface and bulk fluorescence is 
inherent in the enhanced fluorescence capture structure design.
The chip and flowcell were positioned in front of a CMOS camera, bandpass 
filter (centred on 610 nm with FWHM of 10 nm) and variable focal length lens, 
with the flowcell and lens located on opposite sides of the chip. Excitation of the 
chip occurred from behind, as it was found that some of the excitation light was 
absorbed if passed through the flowcell.
Flowcell structured Variable Focus CMOS Camera
chiP Lens
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5 .4 .2  E xp erim en ta l M eth o d
Three of the frustrated cones were printed with undoped sol-gel. Doped sol- 
gel was printed on the top of the other three cones. Three undoped and three 
doped sol-gel spots were also printed on the planar portion of the chip. Following 
printing of the sol-gel layers onto the top of cones, a flowcell was sealed to the chip 
using pressure-sensitive adhesive (optically clear laminating adhesive 8141 from 
3M, PLC, United Kingdom). The printed chip and flowcell were then positioned 
in front of the detector (as described in Section 5.4.1) and a peristaltic pump was 
connected to the flowcell.
The nonfluorescing and fluorescing bulk solutions (doped and undoped water) 
were passed over the surface of the chip using the peristaltic pump. The fluores­
cence emitted from each of the combinations listed in Table 5.4 was recorded.
Combination Surface Layer Bulk Solution
1 Fluorescing Fluorescing
2 Fluorescing Non-fluorescing
3 N on-fluorescing Fluorescing
4 N on-fluorescing N on-fluorescing
Table 5.4: Bulk solution/surface layer combinations investigated.
5.4 .3  Im age A n a ly sis
The image analysis employed in this work was similar to that described in Sec­
tion 5.2.5, with the same custom-written C-based Mathematica program being 
employed. Fluorescence intensity values were recorded for both the frustrated 
cones and the spots printed on the planar surface of the chips. Background 
intensities were subtracted from these figures to give true intensity values.
5 .4 .4  R esu lts
Each of the combinations of bulk solution and surface layer listed in Table 5.4 were 
investigated. As expected, as undoped solution was passed over the frustrated 
cones printed with undoped sol-gel, no fluorescence was detected. Fluorescence 
was detected for each of the other bulk solution/surface layer combinations.
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Several chips printed with doped sol-gel were investigated. Figure 5.18 shows 
representative images of the fluorescence profiles obtained. Similar to the images 
discussed in Section 5.2.6, the spot and ring profile seen on the left-hand-side of 
both images corresponds to the fluorescence recorded from the frustrated cones. 
As explained in Section 5.2.6, the ring profile results from the redirection of the 
substrate-confined fluorescence by the frustrated cones. The spot seen on the 
right-hand-side of the images corresponds to the fluorescence recorded from the 
doped sol-gel printed on the planar portion of the chip. Image (a) was obtained 
when the chip was covered with a non-fluorescing solution and image (b) was 
obtained when the chip was covered with a fluorescing solution.
o
(a) (b)
Figure 5.18: The spot and ring profile seen on the left-hand-side of both images 
corresponds to the fluorescence recorded from doped sol-gel printed on the top of the 
frustrated cone. The spot seen on the right-hand-side of both images corresponds 
to the fluorescence recorded from doped sol-gel printed on the planar portion of the 
chip. Image (a) was obtained when the chip was covered by a non-fluorescing bulk 
solution and image (b) was obtained when the chip was covered by a fluorescing 
bulk solution.
Table 5.5 shows the intensity values obtained for the spot and ring profiles for 
both the fluorescing bulk solution and the non-fluorescing bulk solution. It was 
found that when a non-fluorescing bulk solution was replaced by a fluorescing so­
lution, the intensity of the spots printed on the planar portion of the chip and on 
the top of the frustrated cones increased. However, this increase in intensity was 
not observed in the rings. For each chip investigated, changes in the bulk solution 
had only a negligible effect on the fluorescence intensity of the rings. Calcula­
tion of the mean intensities of the spots and rings when covered by fluorescing 
and non-fluorescing solutions showed that a 85 % increase in spot intensity was
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Total Intensity [arb. units] Intensity Increase [%]
Chip Spot (NFB) Spot (FB) Ring (NFB) Ring (FB) Spot Ring
1 17566 30365 643505 692198 73 7
2 18362 34936 632219 689930 90 8
3 17406 31887 630031 721371 83 13
4 19963 35558 620261 670285 78 7
5 18541 34775 577218 640711 88 10
6 17926 34105 589859 671479 90 12
7 18580 36476 600271 648389 96 7
8 18009 32114 576615 666348 78 13
9 18634 33857 630542 681686 82 8
10 17167 30843 639676 687578 80 7
1 1 19856 37445 665685 708036 89 6
12 18225 35115 612932 678462 93 10
13 17786 33364 640637 665131 88 4
14 18533 34286 570930 644427 85 11
15 19887 35566 602261 687698 79 12
mean 18429 34046 615509 676915 85 9
Table 5.5: Fluorescence intensities and percentage increases of ring and spot pro­
files, obtained when the chips were surrounded by either a fluorescing bulk solution 
(FB ) or a non-fluorescing bulk solution (N FB).
accompanied by an increase in ring intensity of < 1 0 %.
This latter figure indicates a much reduced sensitivity to fluorescence originat­
ing from the bulk solution. This in turn suggests that a significant proportion of 
the fluorescence present in the ring is SC in nature. However, the fact that changes 
in intensity were detected demonstrates that the frustrated cone structure does 
not facilitate complete discrimination between surface and bulk fluorescence.
5 .5  S u m m a ry
In order to determine the feasibility of discriminating between surface and bulk 
fluorescence using the frustrated cone structures, chips containing six of these
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structures were fabricated and printed with both doped and undoped sol-gel. 
Spots were printed on top of the frustrated cones and on the planar portion of 
the chips. Polymer flowcells were used to pass fluorescing and non-fluorescing 
bulk solutions over the chips. The chips were then excited from behind and the 
resultant fluorescence was recorded.
It was found that replacing a non-fluorescing bulk solution with a fluoresc­
ing bulk solution resulted in a 85% increase in intensity of the spots printed 
on the planar portion of the chip but produced an increase in ring intensity of 
< 10%. This result demonstrated that the frustrated cone structures provide 
an increased insensitivity to bulk fluorescence. However, the small increase in 
ring intensity showed that they did not provide complete discrimination between 
the fluorescence originating from the surface and that originating from the bulk.
5 .6  C o n c lu s io n s
A theoretical analysis carried out previously described the angular distribution 
of fluorescence emitted by a radiating dipole at a surface. This chapter detailed 
the experimental work undertaken to verify two predictions made by the analysis, 
namely;
1. Redirection of surface-confined fluorescence results in the enhancement of 
the fluorescence capture efficiency.
2. It is possible to discriminate between fluorescence originating at the surface 
and fluorescence originating from the bulk above the surface.
Based on the theoretical analysis, polymer chips bearing arrays of frustrated 
cones were designed and fabricated. These structures redirected the substrate- 
confined (SC) fluorescence out of the chip and directly onto a detector positioned 
below. Sol-gel spots doped with a ruthenium dye complex were printed on the 
top of the cones and on the planar portion of the chips. The spots were then 
excited and the resultant fluorescence analysed. It was shown that, using the 
set-up described in Section 5.2.4, up to 40 times more fluorescence was recorded 
from the frustrated cones than from the planar portion of the chip. This provided
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strong experimental verification to the first prediction that redirection of the SC 
fluorescence results in the enhancement of the fluorescence capture efficiency.
In order to verify the second prediction, a set-up that facilitated the analysis 
of specific angular ranges was designed and assembled. Employing a sol-gel layer 
as the surface, various combinations of fluorescing and non-fluorescing layers and 
bulk solutions were analysed. The angular ranges that corresponded to the surface 
and bulk solution were identified. It was demonstrated that fluorescence from 
the bulk and surface were emitted in different angular ranges. Specifically, the 
majority of the fluorescence originating from the bulk was emitted at angles below 
the critical angle of the environment/substrate interface.
After providing experimental verification to both predictions, an experiment 
was carried out to verify the inherent ability of the frustrated cones to discrimi­
nate between surface and bulk fluorescence. Sol-gel doped with a ruthenium dye 
complex was printed on the top of the enhancement structures and on a planar 
portion of the chips. It was found that substituting a non-fluorescing bulk solu­
tion with a fluorescing bulk solution resulted in a large increase in the fluorescence 
intensity of the spots on the planar portion of the chip but resulted in only a small 
increase in the intensity of the rings produced by the cones. This demonstrated 
that the cones provided partial discrimination between surface and bulk fluores­
cence. However, the fact that there was an increase in intensity implied that the 
cones are unable to provide complete discrimination between surface and bulk 
fluorescence. Further optimisation of the structure design would be required in 
order to achieve complete discrimination.
It was shown in this chapter that the frustrated cones provide increased flu­
orescence capture compared to conventional planar substrates. Therefore, by 
incorporating these structures into the chip design, as described in Section 5.2.2, 
substantially lower limits of detection should be attainable. Accordingly, the 
next stage of this work involved the replacement of the planar substrate of the 
immunosensor described in Chapter 4 with the structured chip described in Sec­
tion 5.2.2.
I l l
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Chapter 6
D evelopm ent of Enhanced  
Im m unosensor
6.1  In tr o d u c tio n
The structured chip described in Chapter 5 was shown to provide enhanced flu­
orescence capture efficiency compared to planar chips. Therefore, it was decided 
to replace the glass planar substrate employed in the work described in Chap­
ter 4 with the optimised structured polymer chip. New immobilisation strategies, 
printing methods and experimental systems were required in order to effectively 
carry out the replacement. This chapter describes these new systems and presents 
the results from assays carried out using the new optimised chip.
6 .2  A n t ib o d y  Im m o b ilisa tio n
A glass microscope slide was employed as the substrate in the immunosensor de­
scribed in Chapter 4. One of the major advantages of using glass is its established 
surface modification procedures [1]. The development of routine, simple polymer 
surface modification techniques is still in its infancy, with no standard immobili­
sation strategy for antibodies on polymer surfaces yet established. Therefore, in 
order to select a strategy for the immunosensor presented here, it was necessary 
to investigate several different polymer modification methods.
It was decided to immobilise anti-BSA antibodies via the carboxyl groups
113
6.2. Antibody Immobilisation H. M. McEvoy
present at their C termini (see Section 2.2  for more information). This would 
leave the antigen-binding sites available and increase the chances of the antibodies 
being orientated in an upright position. Correct orientation of antibodies on solid 
substrates is important due to its effect on surface coverage and availability of 
binding sites. Carboxyl groups readily bind with amine groups (as shown in 
Section 2 .2 ). Therefore, polymer modifications ultimately resulting in amine 
groups were required.
The optimised chips described in Chapter 4 were fabricated using polymethyl 
methacrylate (PMMA). This polymer consists of a carbon chain backbone with 
methyl ester side chains, as illustrated in Figure 6.1.
O - C H ,
Ic=o
- E c h = - M „
c h 3 n
Figure 6.1: Illustration of structure of polymethyl methacrylate (P M M A ).
As shown in Figure 6.2, there were two possible routes to modify the PMMA 
surface to produce amine groups on the surface:
1. Convert the methyl ester side chains of the PMMA to useful surface func­
tional groups.
2. Apply a generic surface modification method that is independent of the 
polymer employed.
Five separate polymer modification strategies were investigated. The first two 
were specific to the PMMA substrate, while the last three were independent of 
the chemical nature of the substrate. The specific chemical functionalisations of 
the PMMA involved a transamidation reaction and a reduction of the surface 
methyl ester groups. The generic surface modifications involved two radical graft 
polymerisation processes, the first initiated by oxygen plasma treatment and the 
second initiated by UV-curing, and a sol-gel coating of hybrid organic-inorganic
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involving PMMA ester 
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Modification Strategies 
3. 4 and 5
Figure 6.2: The two functionalisation routes (specific and generic) of the polymer 
substrate.
layers on the polymer surface. Each of the 5 different modifications yielded amine- 
terminated surfaces.
Commercial PMMA sheets were obtained from Goodfellow. The PMMA 
sheets were machined to a given size to give PMMA slides (35 mm x 10 mm x
1.0  mm) and rinsed with isopropanol, followed by drying with a nitrogen stream. 
This procedure was followed prior to any of the following chemical treatments on 
the surface of the PMMA slides.
6 .2 .1  P o ly m er  M od ifica tion  and C h aracterisa tion
1. Amino-M odification
The first polymer modification strategy investigated was that of amino-modification 
This involved a transamidation reaction, which is a reaction resulting in the for­
mation of an amide group (structure shown in Figure 6.3).
The first step in the modification exploited the intrinsic reactivity of lithium by 
reacting 1,3-diaminopropane with n-butyllithium to form N-lithioaminopropane 
(see Figure 6.4) [2].
Soper et al. reported that the monoanion of N-lithiodiaminopropane (shown 
in Figure 6.4 as NH- Li+) reacts with the surface methyl esters of PMMA to yield
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g
Figure 6 .3: Structure of amide group. R and R' correspond to hydrogens or alkyl 
groups.
H, N' 'NH ,
VNH LI
Figure 6.4: Reaction of 1,3 diaminopropane with n-butyllithium to form N- 
lithiodiaminopropane.
amine-terminated PMMA [3]. Therefore, PMMA slides were immersed in a solu­
tion of N-lithiodiaminopropane for less than 3 minutes, after which the reaction 
was quenched with isopropanol, followed by de-ionised water. The reaction that 
occurred is illustrated in Figure 6.5.
NH,
h2n'
-J-CH,—
'NH U 
+
0 -C H ,
I 3 Est»
c = o
1—c —
I
CH,
.+
NH
Amid« I |
- [ C H . - Ç — }
c h 3 n
Figure 6 .5 : Illustration of amino-modification of PM M A , using N-
lithiodiamiftopropane, to form P M M A -N H 2 .
The amino-modified PMMA slides were then rinsed with copious amounts of 
isopropanol, followed by de-ionised water and dried under a stream of nitrogen.
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Characterisation of Amino-Modified PM M A
Characterisation of the amino-modificed PMMA slides was achieved using the 
Perkin Elmer UV/VIS/NIR Lamda 900 Spectrometer. Attenuated total reflectance 
(ATR) infrared spectra of the slides were obtained both before and after the 
amino-modification [4]. IR absorption is based on the principle that atoms in 
molecules vibrate at specific frequencies, which are dependent on the bond type 
and method of vibration e.g. stretching or bending. Thus, measuring the ab­
sorption over a range of frequencies, allows the bonds present in the interrogated 
sample to be identified. The spectra of the unmodified PMMA and the PMMA- 
NH2 slides after various reaction times are shown in Figure 6 .6 .
Wavenumber / cm
Figure 6.6: FT-IR  spectra of surface of unmodified P M M A  and N ^ -m odified
P M M A .
The unmodified PMMA spectrum correlates well with the transmission spec­
trum of PMMA documented in the literature [3-5]. The most prominent band is 
the carbonyl stretch, i;(C=0), at ~ 1730cm-1 . The band maximum is charac­
teristic of methyl esters, particularly those found in PMMA films. The remaining 
vibrational bands observed are characteristic of the alkane and ester moieties 
present in the polymer.
With increase of reaction time, a substantial decrease in the intensity of all 
the ester function bands (v(C = 0), v(C-O) and v(C-O-C)) was observed, proving
117
6.2. Antibody Immobilisation H. M. McEvoy
that a reaction involving this group had occurred. The NH2-modified PMMA 
spectra display two new peaks at approximately 1540 cm- 1  and 670-635 cm- 1  
which could be assigned to the amide II stretch (<5(N-H)) and amide IV, V and 
VI bands respectively. These data are in agreement with the replacement of the 
ester functionalities by an amide linkage, as described in Figure 6.5.
In order to quantify the number of amines presence on the surface of the 
PMMA-NH2 slides a ninhydrin test was employed. Fang and Liu described a com­
prehensive study on the use of ninhydrin for the determination of amines, and 
their procedure was followed [6]. Firstly, the amide bonds of the amine-terminated 
PMMA were hydrolysed using HCL, which resulted in PMMA with acid residues 
and diamine in the reaction solution. The solution was then neutralised and 
tested with ninhydrin, which reacts with the amines to produce a coloured prod­
uct. The number of amine molecules present was then determined by comparison 
with a standard curve (shown in Figure 6.7), which was obtained by measuring 
the absorbance of varying concentrations of 1 ,3-diaminopropane at 570 nm.
Figure 6.7: Standard curve obtained with varying concentrations of 1,3-
diaminopropane employing ninhydrin test.
The test proved positive, and the number of amines per cm2 was calculated 
to be approximately 7 nmol per cm2. This value is slightly higher than that 
previously reported [3].
In order to confirm whether even surface coverage of amines on the PMMA 
was obtained, the PMMA-NH2 slides were immersed in a solution containing 
Cy5 dye, which resulted in the fluorescent labelling of the surface amines. After 
removal, washing and drying, the slides were examined using using a Genetic
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Microsystems (GMS) 418 fluorescence scanner. The scanner excited the Cy5 dye 
bound to the surface amines using a 635nm laser and the emitted fluorescence 
was recorded using a microscope and photomultiplier tube. The results were dis­
played as a 2D false colour image. Analysis of the fluorescence intensity recorded 
from the PMMA-NH2-Cy5 slides showed that the amino-modification resulted in 
a reasonably homogenous surface coverage. A representative image is shown in 
Figure 6 .8 . The colour scale ranges from black through blue, green, yellow and 
red to white, where white corresponds to a saturated signal.
Figure 6.8: Fluorescence intensity image from PM M A -N H -C y5 (only bottom por­
tion of slide modified), recorded using a Genetics Microsystems 418 Scanner.
2. Hydroxyl-M odification
Hydroxyl-modification was the second strategy examined. Methyl ester side 
chains of the PMMA were reduced to alcohols using diisobutylaluminium hydride 
(DIBAL), as illustrated in Figure 6.9.
The machined and cleaned PMMA slides were immersed in a solution of 
DIBAL in hexane under nitrogen and stirred at room temperature. After the 
reaction had been completed, the slides were then soaked in isopropanol, fol­
lowed by extensive rinsing with de-ionised water and were finally dried under 
a stream of nitrogen.
The next step of the modification technique was the formation of amines 
on the PMMA surface. Since alcohols are not very reactive towards amines in 
aqueous solution they were converted to cyano-esters, (which are more reactive
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OH
I
CH2
-PcH,—C-------
L '  1 n
ch3 n
Figure 6.9: Schematic of ester reduction to alcohols, using diisobutylaluminium 
hydride.
to amines) before further modification was possible. Cyanogen bromide, dis­
solved in acetonitrile, was added to a solution of sodium carbonate containing 
hydroxyl-modified PMMA slides. The cyanogen bromide was used to react with 
the alcohols present at the PMMA surface to form highly reactive cyano-ester 
groups. The slides were then immersed in a solution of 1, 3-diaminopropane in
0.2M carbonate buffer solution (pH9.0), and stored at 4°C overnight. During this 
time, the cyano-ester groups reacted with the amines present the in solution to 
form amine groups on the surface, as illustrated in Figure 6.10.
Figure 6 .10: Schematic of cyano-ester formation and resultant amine-terminated 
surface.
Characterisation of Hydroxyl-Modified PM M A
ATR infrared spectra of the PMMA slides were obtained before and after the 
hydroxyl-modification. The spectra of the unmodified PMMA slides and the 
modified PMMA-OH slides are shown in Figure 6.11.
+
o - ch3 
! 3 
c = o
-f-CHi—C-------
T " ¿7*
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Wavenumbercm"'
Figure 6.11: FT-IR  spectra of surface of unmodified P M M A  and OH-modified
PM M A .
As was observed with the spectra of amino-modified PMMA slides, the hyroxyl- 
modified PMMA slides show a decrease in intensity of the ester bands (k(C=0), 
v(C -0)  and v(C-O-C)). The emergence of anew large band centered at 3320 cm-1 , 
corresponding to OH stretching frequencies of the alcohol from the reduced es­
ter, was also observed [4]. These data confirm the chemical reaction depicted in 
Figure 6.10. The evolution of the spectra shows that leaving the PMMA slide in 
DIBAL (hexane) for one hour was adequate time for the reaction to occur.
The surface coverage of the hydroxyl groups was measured using an aniline 
blue stain, which attached only to hydroxyl groups and was subsequently analysed 
using optical microscopy. Examination of the slides showed relatively uneven 
surface coverage of hydroxyls. Unmodified PMMA exposed to the same conditions 
showed only trace background difference to “blank” PMMA. The results are shown 
in Figures 6.12 .
Following the modification of the PMMA-OH slides to PMMA-OH-NH2, the 
amine surface coverage was examined. In order to facilitate comparisons between 
modification strategies, the method employed to examine the surface coverage in 
Section 6 .2 .1  was also employed here. Cy5 dye was bound to the amines on the 
modified surface and analysed using the fluorescence scanner. A representative 
fluorescence intensity image is shown in Figure 6.13, illustrating the relatively
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(a) (b)
Figure 6.12: (a) Surface of unmodified P M M A  after staining with aniline blue, (b) 
Surface of P M M A -O H  after staining with aniline blue.
uneven surface coverage, supporting the aniline blue stain test results. Both 
the amino-modified PMMA slides and the hydroxyl-modified slides resulted in 
similar values of fluorescence intensity but the hydroxyl-modification produced 
less homogenous amine coverage.
Figure 6.13: Fluorescence intensity image from PM M A -O H-N H2-Cy5 (only bottom 
portion of slide modified), recorded using a Genetics Microsystems 418 fluorescence
scanner.
3. Carboxyl-M odification via Oxygen Plasm a
The third and fourth modification strategies were based on graft polymerisation, 
whereby polymers with useful functional groups were grafted onto the PMMA 
substrate. The polymers were formed from vinyl monomers, which are molecules 
containing carbon-carbon double bonds. In order to start the polymerisation
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process, an initiator was required to break the double bonds of the monomers.
These bonds were then used to link the monomers into chains, via chain propaga­
tion [7]. In both strategies presented here, free radicals were employed to initiate 
the polymerisation process. In the first strategy, radicals were generated on the 
PMMA surface via an oxygen plasma.
Plasmas are ionised gases, which can be generated by applying high temper­
atures or strong electric or magnetic fields to a gas [8]. In this work, unmodified 
PMMA slides were inserted into a plasma chamber and an oxygen plasma was 
generated using an electric field. When placed in a plasma, the polymer surface 
is exposed to a broad spectrum of ions, electrons, neutral molecules, radicals, 
and electromagnetic radiation, each of which modify the first few nanometers of 
the polymer surface. These different species strongly interact with the polymer, 
resulting in chemical and physical modifications of the surface.
It is not possible to give a precise mechanism of the chemical modification 
involved in the plasma treatment. This is due to the great reactivity of the 
compounds involved and the multiplicity of oxidation mechanisms that can be 
proposed for PMMA. Very few descriptions have been provided in the literature, 
as the numerous highly-reactive species involved in the surface modifications are 
not well defined. An example of some of the possible reactions, proposed by Chai 
et al., are shown in Figure 6.14 [9].
As a result of the plasma treatment, free radicals were formed on the PMMA 
surface. Upon printing of the monomer, methacrylic acid, onto the surface, these 
radicals initiated the graft polymerisation, coupling with the active methacrylic 
acid species to form the co-polymer, as illustrated in Figure 6.15.
The carboxyl-modified PMMA was further treated with N-(3-Dimethylaminopropyl)- 
N-ethylcarbodiimide hydrochloride (EDC), which acted as a catalyst in the bind­
ing of the acid and amine groups, and upon addition of 1,3-diaminopropane, 
amines were formed on the surface of the PMMA (as shown in Figure 6.16).
Characterisation of Carboxyl-Modified (via Oxygen Plasma) PM M A
Toluidine blue dye, which contains a free amine group, was used to indicate the 
presence of carboxyl groups on the PMMA slides [10]. A solution of toluidine 
blue stain was prepared by dissolving 0.025g toluidine blue in lOOmls 0.01 N HC1,
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Figure 6.14: Examples of possible oxidation schemes for oxygen plasma-treated 
PMMA.
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R* u r  =
i ‘ COOH
PMMA Substrate Radical Methaciylic Acid
(formed on surface 
via oxygen plasms)
Figure 6 .15: Reaction of oxygen plasma-treated P M M A  with methacrylic acid.
PMMA-COOH
O
PMMA- "NH,
Figure 6.16: Formation of PM M A -C O O H -N H 2 .
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containing 0.2% w/v NaCl. The carboxyl-modified PMMA slides were immersed 
in this solution for 10  minutes, followed by thorough rinsing with de-ionised wa­
ter and dried under a stream of nitrogen. The toluidine blue dye attached to the 
carboxyl groups present on the surface of the slide and was imaged using optical 
microscopy. Figure (a) shows an image of unmodified PMMA stained with tolu­
idine blue and Figure (b) shows an image of carboxyl-modified PMMA stained 
with toluidine blue. There is a definite increase in carboxyl groups on the surface 
but the surface coverage is relatively uneven.
(a) (b)
Figure 6.17: Image of toluidine blue stained P M M A  slides. Image (a) corresponds 
to unmodified P M M A . Image (b) corresponds to carboxyl-modified (via O 2 plasma) 
PM M A .
To facilitate the comparison of surface coverage of each of the immobilisation 
techniques, Cy5 dye was attached to the amine-terminated carboxyl-modified 
PMMA slides and analysed using the fluorescence scanner. A representative 
fluorescence image obtained is shown in Figure 6.18.
The fluorescence intensity values recorded using the carboxyl-modification 
via oxygen plasma method were comparable to those from both the hydroxyl- 
modification and amino-modification. However, as can be seen from Figure 6.18, 
a relatively uneven surface coverage of amines was obtained. This was in agree­
ment with the toluidine blue test results. A possible explanation for the uneven 
coverage could lie with the two-step nature of the procedure: first the substrate 
is activated and subsequently the monomer is printed. As the radicals are highly 
reactive, several of them could react with one another to form non-reactive com­
pounds before the monomer is printed. This would result in a lack of radicals in 
some parts of the substrate, leading to an uneven layer.
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Figure 6.18: Fluorescence image of Cy5 dye immobilised on carboxyl-modified (via 
O 2 plasma) P M M A  slide. Only the bottom portion of the slide was modified.
4. UV-cured Graft Polymerisation
The fourth modification strategy investigated was also based on graft polymeri­
sation. In this case, UV irradiation was employed to promote the free radicals 
required for initiating the polymerisation process. The photon energy of UV light 
is high enough to excite and dissociate various organic chemical bonds and form 
free radicals on the polymer surface. These radicals subsequently react with ac­
tivated oxygen species simultaneously generated through the photoexcitation of 
atmospheric oxygen molecules.
In this work, the initiator and monomer, acetophenone and methacrylic acid 
respectively, were mixed together and printed onto the PMMA surface. The 
initiator was then split using UV radiation, leaving each initiator fragment with 
one unpaired electron (free radical). As stated in Section 6.2.1, methacrylic acid 
contains a carbon-carbon double bond that is easily attacked by the free radical. 
This results in the addition of the free radical to the monomer. This process 
repeats itself, resulting in the formation of polymer chains, only terminating 
when two radical species form. The UV irradiation results in the formation of 
radicals, not only in the initiator but also on the PMMA substrate (both via the 
UV-irradiation and via a chemical reaction between the photoinitiator and the 
polymer substrate), resulting in the anchorage of the reactive layer to the PMMA 
surface [11,12], The process is illustrated in Figure 6.19.
As described in Section 6 .2 .1 , amine groups were formed on the carboxyl-
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Figure 6.19: Mechanism of UV-cured graft polymerisation.
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modified PMMA slides via immersion in a solution containing 1,3-diaminopropane 
and EDC (see Figure 6.16).
Characterisation of UV-cured Graft Polymerisation Treated PM M A
The toluidine blue test described in Section 6.2.1 was repeated for the carboxyl- 
modified (via UV-cured graft polymerisation) PMMA slides. The toluidine blue 
dye attached to carboxyl groups present on the surface of the modified slides and 
was recorded using optical microscopy.
Examination of the stained slides showed a relatively even surface coverage of 
carboxyls on the UV-cured carboxylated PMMA and suggests that the UV-cured 
treatment produces a more homogenous surface carboxyl population than the 0 2 
plasma treatment.
To facilitate comparison between strategies, Cy5 dye was immobilised on the 
amine-terminated, carboxyl-modified PMMA slides. The labelled slides were sub­
sequently examined using the fluorescence scanner and analysis showed a rela­
tively homogenous surface coverage (see Figure 6.20). A table listing fluorescence 
intensity values for each of the strategies is included at the end of Section 6.2.1.
Figure 6.20: Fluorescence image of Cy5 dye immobilised on carboxyl-modified (via 
UV-cured graft polymerisation) P M M A  slides. Only the bottom portion of the slide 
was modified.
The fluorescence intensity values obtained via this modification strategy were 
slightly higher than those recorded from the other strategies, with a relatively 
even amine surface coverage obtained. A possible explanation for this relatively
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homogeneous surface coverage could be that, in this method, the monomer and 
initiator form an even layer before polymerisation. Polymerisation then occurs 
simultaneously from the layer to the surface and from the surface to the layer. 
This is in contrast to the plasma treatment method, where the polymerisation 
induced by the plasma treatment is rather anisotropic due to the presence of 
radicals only on the PMMA surface and the two-step process discussed previously.
5. Silica-Modification
The final modification strategy investigated was similar to the third and fourth, 
in that a grafted layer was covalently attached to the PMMA surface. However, 
in this case, a sol-gel layer, rather than a polymer, was grafted onto the PMMA 
surface. As explained in Section 5.2.4, the sol-gel process results in the formation 
of a glass at low temperatures. Therefore, following the formation of the sol-gel 
layer, well established glass chemistries could be employed to attach antibodies 
to the substrate surface.
A tetraethyl-orthosilicate (TEOS)-based sol was prepared by mixing TEOS,
0.1 N hydrochloric acid and ethanol absolute and leaving the solution to age 
overnight. An oxygen plasma was used to generate reactive groups/radicals on 
the PMMA surface. These treated slides were then coated with the TEOS-based 
sol via dip-coating, which, as explained in Section 5.3.2, is a process that involves 
the immersion and withdrawal of the slides from a sol. For this work, a dip- 
coating rate of 2mm/s was employed, after which, the chips were cured at 70°C 
for 6 hours, resulting in a TEOS based layer approximately 500 nm thick.
In order to form amine groups on the surface of the TEOS-coated PMMA 
slides, the organosilane, 3-aminopropyltriethoxysilane, was employed (see Sec­
tion 4.3.2 for information on organosilanes). After incubating the slides in this 
solution, amine functional groups were formed on the surface, as illustrated in 
Figure 6.21.
Characterisation of Silica M odified-PM M A
In order to compare amine surface coverage with that of each of the other immo­
bilisation strategies, Cy5 dye was attached to the amine groups present on the
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PMMA-TEOS (EtO)gS PMMA-NI-^
Figure 6.21: Reaction of TEOS-coated P M M A  with organic amino-silane, to form 
P M M A -TE O S -N H 2.
surface of the PMMA-TEOS-NH2 slides. After removing the slides from the so­
lution they were washed and dried and the amine surface coverage was examined 
using the fluorescence scanner. A representative fluorescence image is shown in 
Figure 6.22.
Figure 6.22: Fluorescence image of Cy5 dye immobilised on P M M A  slide via sol-gel 
coating. Sol-gel coated on bottom portion of slide only.
Compared to the previous strategies employed, a relatively high level of flu­
orescence was obtained using the silica-modified PMMA slides. However, the 
surface coverage was quite non-homogeneous. Mean fluorescence values obtained 
via each strategy are presented in Section 6.2.1.
Attachment of Chains
The main aim of the surface modification was the effective immobilisation of anti­
bodies. Work carried out by Hoffman et al. showed that antibody immobilisation 
directly onto a polymer surface can result in low levels of antigen binding due 
to steric crowding and restricted antibody movement [13]. They overcame this 
problem by employing molecular chain extensions. Antibodies attached via chains
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should have greater freedom of movement, thus reducing the steric hindrance and 
thereby increasing the number of available antigen-binding sites. Hoffman et al. 
reported the greatest increase in antigen binding and sensor sensitivity when the 
molecular chains employed were greater than 20 atoms in length.
Therefore, in order to reduce the potential problems of steric hindrance and 
increase the number of available antigen binding sites, the use of molecular chain 
extensions was investigated. The chains were formed by immersing the PMMA 
slides with terminal NH2 functionalities (PMMA-NH2, PMMA-OH-NH2, PMMA- 
COOH-NH2, PMMA-TEOS-NH2) in 0.2M carbonate buffer solution (pH9.0), to 
which succinic anhydride was added. The succinic anhydride reacted with the pri­
mary amine groups in a ring-opening process, creating an amide bond and forming 
a terminal carboxylate (see Figure 6.23). This solution was stirred overnight at 
room temperature to ensure all sites had reacted and the slides were subsequently 
rinsed with de-ionised water and dried under nitrogen.
H i h 2
P M M A  n h  c — c — c — c — OH
II IIo o
Figure 6 .23 : Formation of amide bond with terminal carboxylate.
As with each of the modification strategies described previously, the modified 
PMMA slides were immersed in 0.1 M phosphate buffer (pH7.0), to which EDC 
was added, followed by a 5 % solution of 1,3-diaminopropane in 0.1 M phosphate 
buffer (pH7.0). The terminal carboxylate reacted with the amines in the solution, 
creating an amide bond and forming a terminal amine group (see Figure 6.24). 
This reaction mixture was stirred at room temperature for 4 hours, after which 
the slides were rinsed with de-ionised water and dried under a stream of nitrogen.
This formation of a terminal carboxyl group, followed by the formation of 
a terminal amine group was repeated until a chain length away from the surface 
of the PMMA substrate of greater than 20 atoms was achieved. The final spacer 
was comprised of 26atoms (approximately 32 A), as shown in Figure 6.25.
P M M A  N H j +
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Figure 6.24: Formation of amide bond with terminal amine group.
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Figure 6.25: (a) Structure of extended chains from surface of P M M A  (b) Molecular 
model of extended chains from surface of P M M A , modelled using Chem-3D.
Characterisation of PM M A  with Chains Extensions
In order to complete the comparison, Cy5 dye was coupled to the PMMA slides 
modified with molecular chain extensions, terminating in amine groups. PMMA- 
NH2, PMMA-OH-NH2, PMMA-COOH-NH2 (both 0 2 plasma and UV-cured) and 
PMMA-TEOS-NH2 slides were each immersed in 0 .2M carbonate buffer solution 
(pH9.0), to which Cy5 dye was added. This solution was left at room temperature 
for 30 minutes, after which the slides were rinsed with de-ionised water and then 
dried under a stream of nitrogen.
Mean intensities for each immobilisation strategy (for both direct immobili­
sation and via molecular chain extensions) were calculated and are presented in
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Table 6.1.
Cy5 dye 
Immobilisation Strategy
Mean Intensity 
Direct (a.u.)
Mean Intensity 
Chains (a.u.)
Amino-modification 
Hydroxyl-modification 
Carboxyl-modification (via O2 plasma) 
Carboxyl-modification (UV-cured) 
Silica-modification
23 ± 4 
14 ± 7 
45 ± 14 
61 ± 7 
65 ± 16
40 ± 3 
16 ± 2 
28 ± 1 1  
48 ± 2 
20 ± 13
Table 6.1: Mean intensity values recorded from Cy5 dye coupled to P M M A  slides 
using each of the immobilisation strategies, via both direct immobilisation and 
molecular chain extensions.
Analysis of the fluorescence images showed that there was no significant in­
crease in fluorescence intensity when molecular chain extensions were employed, 
compared to when the Cy5 dye was attached directly to the modified slides. This 
was as expected, as the chains were employed specifically for use with the an­
tibody immobilisation, to reduce the problems of steric hindrance and reduced 
antibody movement. As these are not major issues with the immobilisation of 
Cy5 dye, the chains were not expected to provide increased dye immobilisation.
6 .2 .2  A n tib o d y  B in d in g
Cy5-labelled anti-BSA antibodies were coupled to PMMA slides via each of the 
five immobilisation strategies described in Section 6.2.1, using both direct at­
tachment and molecular chain extensions. The slides were analysed using the 
fluorescence scanner. Representative fluorescence images obtained for each slide 
are shown in Figure 6.26.
Mean intensities for each immobilisation strategy were calculated and are 
presented in Table 6.2.
Fluorescently-labelled antibodies were successfully immobilised via each of 
the five immobilisation strategies. Most of the strategies produced comparable 
levels of fluorescence signal, indicating that none was significantly better than 
the others in terms of signal level obtained.
In contrast to the immobilised Cy5 dye, a trend was observed with regards
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(a) (b) (c) (d)
(e) (f) (g) (h)
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Figure 6.26: Fluorescence images of Cy5-labelled anti-BSA antibodies immobilised 
on P M M A  slides. Figures (a) and (b) correspond to P M M A -N H 2 direct and chains 
respectively, (c) and (d) to  PM M A -O H  direct and chains, (e) and (f )  to P M M A - 
COOH (via O2 plasma) direct and chains, (g) and (h) to PM M A -C O O H  (UV-cured 
graft polymerisation) direct and chains and (i) and (j) to PM M A -TEO S direct and 
chains.
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Cy5 dye-Labelled Antibody 
Immobilisation Strategy
Mean Intensity 
Direct (a.u.)
Mean Intensity 
Chains (a.u.)
Amino-modification 
Hydroxyl-modification 
Carboxyl-modification (via O2 plasma) 
Carboxyl-modification (UV-cured) 
Silica-modification
21 ± 4 
26 ± 4
22 ± 3 
37 ± 3 
44 ± 19
80 ± 9
83 ±  4 
79 ± 4
84 ± 11 
43 ± 6
Table 6.2: Mean intensity values (a.u.) recorded from Cy5-labelled anti-BSA  
antibodies coupled to P M M A  slides using five separate immobilisation strategies, 
via both direct immobilisation and molecular chain extensions.
to higher intensities of fluorescence from antibodies attached via molecular chain 
extensions when compared to antibodies attached directly to the surface of the 
PMMA slides. This was as expected, as direct attachment of antibodies would 
imply restricted movement of the antibody and greater steric crowding, thus low­
ering the concentration of antibodies at the substrate surface. Antibodies further 
from the surface should have greater freedom of movement, increasing the po­
tential for enhanced surface coverage. However, immobilisation of antibodies via 
chains using the TEOS immobilisation strategy resulted in a decrease in the flu­
orescence signal recorded when compared to that from the direct immobilisation. 
A possible explanation for this result is that, due to the thickness of the TEOS 
coating on the PMMA slide, when the dye is bound via molecular extensions it 
so far from the surface of the substrate that it is no longer in the focus of the 
fluorescence scanner. This is a likely explanation as the TEOS film is already of 
the order of 500 nm thick.
Due to the lack of significant variation in surface homogeneity of the labelled 
antibodies, it was necessary to employ alternative selection criteria in the choos­
ing of an immobilisation strategy for use with the polymer-based immunosensor. 
Ultimately, the UV-cured graft polymerisation plus chains strategy was selected. 
This was due to its relatively simple protocol, the non-toxicity of the chemicals 
required for its implementation and the fact that it is a generic modification 
strategy that is independent of the polymer employed.
136
6.2. Antibody Immobilisation H. M. McEvoy
6 .2 .3  A ssay  on  P o lym er  S u b stra te
It was necessary to validate the use of the UV-cured graft polymerisation and 
chains method as an effective antibody immobilisation strategy for a polymer- 
based immunosensor. Therefore, a BSA/anti-BSA assay was carried out using 
the sensor system described in Section 4.5, with the glass substrate substituted 
by a planar PMMA slide.
The PMMA slide was coated with a solution of methacrylic acid and ace- 
tophenone and UV-radiated for one hour. Following the radiation, the slide was 
treated with EDC and 1,3-diaminopropane, resulting in the formation of amines 
on the surface.
Subsequently, a BSA/antiBSA sandwich assay was carried out as described 
in Section 4.4, with capture anti-BSA antibodies immobilised on the polymer 
substrate and decreasing concentrations of BSA passed above. The excitation, 
detection and analysis systems employed were the same as those employed with 
the glass substrate (see Section 4.5).
A full dose response curve was successfully obtained and is shown in Fig­
ure 6.27.
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Figure 6.27: Dose response curve for BSA/anti-BSA assay (repeated three times), 
obtained using PMMA-based immunosensor, employing the UV-cured graft poly­
merisation antibody immobilisation strategy.
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As with the glass substrate-based immunosensor described in Chapter 4, as 
the antigen concentration decreased, so too did the fluorescence intensity. A com­
parable working range of greater than 100,000 ng/ml of antigen to 1 0 0 ng/ml was 
attained. As before, the data was fitted to a sigmoidal four-parameter logistic 
equation, with R2 = 0.9926 [14]. The minimal detectable signal (MDS) was cal­
culated from the mean zero response plus 3cr, where a represents the standard 
deviation and the mean zero response is the intensity value recorded when no 
antigen is present. The corresponding limit of detection for BSA was approxi­
mately 300 ng/ml. This was slightly higher than that achieved using the glass 
substrate-based immunosensor, which provided a limit of detection of 150 ng/ml. 
Similar to the glass-based immunosensor, the MDS of the system coincided with 
the lowest concentrations of BSA detected. Though this meant that it was not 
possible to state if the limit of detection was due to the sensitivity of the antibod­
ies or due to the MDS of the system, the aim of proving that the UV-cured graft 
polymerisation and chains method was a viable antibody immobilisation strategy 
was successfully achieved.
6 .2 .4  Su m m ary
Replacement of the planar glass substrate of the immunosensor described in Chap­
ter 4 with the structured polymer platform presented in Chapter 5 meant that the 
antibody to glass immobilisation techniques employed previously were no longer 
applicable. Antibody to polymer immobilisation is a relatively new area of re­
search and consequently, no standardised strategy has been adopted yet. There­
fore, several different immobilisation techniques were investigated. Antibodies 
were successfully immobilised on a polymer substrate via five separate modifi­
cation strategies, namely, amino-modification, hydroxyl-modification, carboxyl- 
modification via oxygen plasma, carboxyl-modification via UV-cured graft poly­
merisation and silica-modification. The effect of molecular chain extensions was 
also investigated and applied to each of the five strategies.
No significant difference in antibody surface coverage was recorded using each 
of the methods. Therefore, due to its ease of use and the non-toxicity of the 
chemicals employed, the UV-cured graft polymerisation plus chains method was 
selected as the immobilisation strategy for use with the enhanced immunosensor.
138
6.3. Patterning H. M. McEvoy
To demonstrate its effectiveness, a full BSA/anti-BSA assay was carried out on 
a planar polymer substrate. A limit of detection for BSA of 300ng/ml was 
obtained, which was comparable to the limit of detection for BSA obtained using 
the planar glass immunosensor.
6 .3  P a tte r n in g
After the antibody immobilisation strategy had been selected, the next area that 
required development before the optimised immunosensor could be completed 
was that of the patterning techniques.
6 .3 .1  P in -P r in tin g
The initial immunosensor (described in Chapter 4) was based on a planar glass 
substrate and was patterned using an Affymetrix Arrayer. However, the Arrayer 
is designed specifically for the patterning of arrays of spots onto planar substrates, 
meaning that it was not readily adaptable for use with the structured substrates 
of the optimised immunosensor.
In order to efficiently pattern the structured substrates a new patterning tech­
nique had to be employed. Several techniques were investigated and a Genomic 
Solutions OmniGrid Micro Pin-Printer was chosen as the most suitable for this 
application (see Figure 6.28). The main advantage of the Pin-Printer over the 
Arrayer was the ease of the z-axis control, which allowed the frustrated cone 
structures to be easily incorporated into the pattern.
The Pin-Printer is designed to transfer solution from either a 96 or a 384 well 
plate to defined locations on the substrates. Each part of the printing process 
is programable, including the wash and dry functions, meaning that once a pat­
terning program was written, it could be run completely automatically, without 
any manual input required. Split pins, supplied by Telechem (Sunnyvale, CA, 
USA), were employed to deposit the antibody solutions onto the substrate sur­
face. These pins have defined uptake channels and flat tips, which facilitate the 
formation of thin drops (approximately 25 /jm) on the tips. The drop is gen­
tly transferred to the substrate without the pin coming into contact with the 
substrate (as illustrated in Figure 6.29).
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Figure 6.28: Genomic Solutions OmniGrid Micro Pin-Printer.
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The split pins provide superior spot size consistency compared to solid pins, 
with the mean spot diameter of the spots in the work presented here equal to 
50 fjLm ± 10 ¡im. The diameter of the spots was affected by several controllable 
printing parameters such as humidity, dwell time and fill time. Larger spot diam­
eters (10 0 ’s of ¿¿ms) were achieved by reducing the separation between the spots 
sufficiently for them to merge to form a single large spot.
The pin-printer was employed to pattern the first level of the antibody as­
say. Applying the UV-graft polymerisation modification strategy described in 
Section 6.2.1, 300 ¿¿m diameter methacrylic acid spots were formed on the top 
surface of the optimised immunosensor’s frustrated cones. This meant that, after 
blocking the rest of the immunosensor substrate, each subsequent layer of the 
antibody assay should attach only at these defined locations.
6 .3 .2  M icroflu id ics
The pin-printer was used to precisely define the location of the first layer of the 
antibody assay. Microfluidics were employed to pass the subsequent layers over 
the immunosensor surface, allowing them to bind to the previous layer. They 
also facilitated the necessary washing and blocking steps.
The initial planar immunosensor employed a reuseable PDMS flowcell to intro­
duce the antibody assay solutions (see Section 4.4.2). In the case of the optimised 
immunosensor, PMMA flowcells were employed. The polymer immunosensor was 
fabricated via micro-injection moulding (as described in Section 5.2.3), with a 
flowcell incorporated into the design of the brass master. Thus, both substrates 
and flowcells could simultaneously be fabricated quickly and simply, further lead­
ing to a complete single-use, disposable immunosensor biochip.
Once the initial layer had been printed onto the tops of the frustrated cone 
structures, the immunosensor substrate and flowcell were sealed using pressure 
sensitive adhesive (PSA). A water-tight seal was formed by simply applying the 
PSA to the edges of the flowcell and bringing it firmly into contact with the 
substrate for 5mins.
Similar to the set-up employed for the planar immunosensor (described in Sec­
tion 4.4.2), a peristaltic pump was employed to pass the antibody assay solutions 
through the polymer biochip.
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6 .4  E x p e r im en ta l an d  A n a ly s is  S y stem s
The experimental and analysis systems employed for use with the planar im- 
munosensor (see Section 4.5) were both modified for use with the structured 
optimised immunosensor. The major difference between the two systems was the 
replacement of evanescent wave excitation with direct excitation of the biochip. 
This greatly simplified the optics, removing the need for the line generator, cylin­
drical lens and the precision alignment required for coupling and evanescent wave 
generation. The 635nm laser diode, filter and cooled CCD camera were all re­
tained, with only the GRIN lens array being replaced with a variable focus lens. 
A schematic of the set-up is shown in Figure 6.30.
Filter .  Cooled
From Pump
To Pump
Figure 6.30: Schematic of excitation and detection system modified for use with 
the structured optimised immunosensor.
The custom-written image analysis program employed with the planar im­
munosensor system (see Section 4.5.3) was modified in-house to include a Visual 
Basic Interface. The previous version facilitated the comparison of selected rect­
angular areas of different images to be compared. As the frustrated cone struc­
tures resulted in circular intensity profiles, the program was updated (in-house) 
to allow circular areas of the recorded images to be selected and compared in 
terms of intensity.
cell Structured c u d  camera
Laser
Diode
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6 .5  S en sor  P erfo rm a n ce
6 .5 .1  S y stem  V alid ation
In order to test each of the procedures and systems described in this chapter, 
a bovine serum albumin (BSA)/anti-BSA competitive assay was carried out on 
the structured biochips. For ease of comparison, the same stock solutions em­
ployed in Section 4.6 were also employed here. The surface of the structured 
biochips were modified using the graft polymerisation strategy described in Sec­
tion 6 .2 .1 . Anti-BSA antibodies were subsequently patterned onto the top of 
the frustrated cones (via molecular chains) using the Genomic Solutions Omn- 
iGrid Micro Pin-Printer (see Section 6.3.1). Known quantities of Cy5-labelled 
and unlabelled BSA were passed above the structured biochip and competed for 
the antibody binding sites (see Section 2.5.3 for more information on competitve 
assays). Unbound BSA molecules were washed away and labelled BSA bound to 
the surface of the biochip were excited using a 635nm laser diode. Fluorescence 
emitted from the bound labelled BSA molecules was recorded using the CCD 
camera-based detection system described in the previous section. The custom- 
written analysis program was used to correlate pixel intensities of the fluorescence 
images with antigen (BSA) concentration. A representative fluorescence image is 
shown in Figure 6.31, illustrating the typical spot and ring profile obtained.
O
Figure 6.31: Representative fluorescence image obtained using the enhanced im- 
munosensor.
The spot in the center of the image shown in Figure 6.31 corresponds to the 
fluorescence emitted from labelled BSA molecules immobilised on the top of the 
cone. The ring profile corresponds to the SC fluorescence that was redirected onto
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the CCD camera by the frustrated cones, which would have been undetected if 
a planar substrate had been employed. The recording of these images verified 
that the assay had been successfully carried out and that each of the procedures 
and systems described in this chapter worked effectively.
6.5.2 Dose Response Curve
In order to investigate the sensor performance a full dose response curve was ob­
tained using the enhanced immunosensor. Varying concentrations of Cy5-labelled 
BSA were mixed with a known concentration of unlabelled BSA. Competitive as­
says were then carried out on the optimised immunosensor using these solutions. 
For each concentration of Cy5-labelled BSA, a different fluorescence intensity 
was recorded. These intensities were plotted against concentration in order to 
produce the dose response curve shown in Figure 6.32.
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Figure 6.32: Dose response curve for BSA/anti-BSA assay carried out using the 
enhanced immunosensor (assay repeated three times).
As occurred in the data analysis of the planar immunosensor described in 
Chapter 4, the data was fitted to a sigmoidal four-parameter logistic equation, 
with R2 = 0.9969 [14], A minimal detectable signal (MDS) (calculated from the 
mean zero response plus 3a) of 0.2745 was calculated. This was significantly lower
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than the signal obtained for the lowest BSA concentration measured. Therefore, 
unlike the planar immunosensor, using the enhanced immunosensor it was pos­
sible to determine the antibody sensitivity, as opposed to the limit of detection 
of the system. The limit of detection for BSA of this stock of antibodies was 
calculated as approximately 7 ng/ml (mean final plateau response plus 3cr). Both 
this limit of detection and the working range obtained are comparable to similar 
immunosensors detailed elsewhere [15,16]. Furthermore, it should be noted that 
due to the low MDS obtainable, by employing antibodies with higher sensitivities, 
the enhanced immunosensor provides the capability to detect significantly lower 
concentrations of antigens.
6 .6  C o n c lu s io n s
This chapter described the integration of the structured chip developed in Chap­
ter 5, with the planar immunosensor presented in Chapter 4. A major challenge 
of this work resulted from the fact that the antibody immobilisation now took 
place on a polymer substrate as opposed to a glass substrate. As explained in 
Chapter 1, this is a very new area of research and consequently, no standard 
immobilisation strategy for polymer has been adopted.
Therefore, five separate covalent antibody to polymer immobilisation strate­
gies were investigated for use with the immunosensor and the effect of molecular 
chain linkers was also examined. The UV-cured graft polymerisation strategy was 
selected and its effectiveness validated by obtaining a full dose response curve us­
ing a polymer-based immunosensor.
The patterning, excitation, detection and analysis systems developed for the 
planar immunosensor presented in Chapter 4 were each optimised for use with 
the structured polymer platforms. A BSA/anti-BSA assay was subsequently per­
formed, validating each of the components of the optimised immunosensor and 
a detection limit for BSA of 7 ng/ml was obtained, which is comparable to similar 
published immunosensors. Most importantly, the minimum detectable signal was 
significantly lower than that of the planar immunosensor. Consequently, this en­
hanced immunosensor has the capacity to detect significantly lower concentrations 
of antigens. This has important implications in the area of medical diagnostics, 
for example, where often only small quantities of analyte are available and there
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exists the need to detect toxins that are fatal at low doses.
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Chapter 7 
Conclusions
The need for detection of potential biohazards exists in a wide range of areas, 
including medical diagnostics, food safety, environmental pollution control and 
biological warfare agent detection. Biosensors are being developed to fulfill this 
need, with the selectivity and sensitivity provided by antibodies and their cor­
responding antigens making them attractive sensing agents. As immunosensor 
research is still at an early stage, they are not yet fully established in these areas 
and there is considerable further development required.
Fluorescence-based immunosensors offer several advantages over alternative 
transducer types, including ease of use, range of application areas and lower 
costs. Optimisation of these sensors requires a truely multidisciplinary approach, 
with their fabrication and operation combining areas of biology, chemistry and 
physics.
The first aim of this thesis was to integrate these fields through the establish­
ment of the techniques and systems required to produce an effective immunosen­
sor. Chapter 4 described how this objective was achieved and provided details of 
the development of strategies for antibody preparation, immobilisation, pattern­
ing, excitation, detection and validation.
Following the establishment of these techniques, the next focus of the work 
was on enhancement strategies. Consequently, research was carried out on the en­
hancement of fluorescence signal capture and the discrimination between surface 
and bulk fluorescence. The ability to detect low fluorescence signals is extremely 
desirable due to the fact that many analytes are toxic at low concentrations, with 
often only small quantities of antibodies or analytes available. The ability to
149
H. M. McEvoy
distinguish between surface and bulk fluorescence would eliminate the need to 
remove fluorescent bulk solution, thus simplifying the immunosensor design and 
operation. This in turn would reduce the cost and operation time, allowing the 
performance of rapid testing by unskilled operators (e.g. in the doctor’s surgery).
Chapter 5 described the completion of the second objective of this work, 
namely, the experimental verification of the theoretical prediction that fluores­
cence signals can be increased via re-direction of substrate-confined modes and 
also that it is possible to discriminate between surface and bulk fluorescence. 
Based on this work, structured polymer chips were designed and fabricated. The 
chips were shown to significantly increase the fluorescence capture of ruthenium- 
complex dye-doped sol-gel, with mean enhancement factors of 35 achieved. It 
was demonstrated that the ability to partially discriminate between surface and 
bulk fluorescence was inherent in these chips but complete discrimination was not 
possible with this design. Following the demonstration of the fluorescence signal 
enhancement, the third aim of this thesis was to incorporate this structured chip 
with the systems presented in Chapter 4, to produce an enhanced immunosensor.
There were several challenges to overcome in the integration of the structured 
chip with the techniques developed in Chapter 4. The initial immunosensor was 
based on a glass substrate. However, the structured chips were formed from 
polymer, which meant that the antibody immobilisation strategy described in 
Chapter 4 was not applicable to this substrate. The area of antibody to poly­
mer immobilisation is an extremely new area of research and consequently, no 
standard immobilisation strategy has been adopted as of yet. Therefore, several 
separate antibody immobilisation strategies were investigated for use with the 
structured polymer chips. Chapter 6 detailed the implementation and charac­
terisation of each of these strategies and demonstrated the effect of molecular 
chain extensions. UV-cured graft polymerisation (plus chains) was selected as 
the immobilisation strategy of choice and was validated through the successful 
attainment of a full dose response curve for BSA/antiBSA. The adaptation of each 
of the other systems for use with the structured polymer chip was also detailed 
in this chapter. Finally, validation of the optimisations and of the enhancement 
capabilities of the chip were demonstrated via the completion of a BSA/antiBSA 
assay. A working range and limit of detection for BSA comparable to those of 
similar published immunosensors was obtained and enhanced fluorescence signal
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capture was achieved, with the minimum detectable signal recorded being lower 
than that of the planar glass-based immunosensor. As stated previously, this 
ability to increase the fluorescence capture signal has important implications for 
sensing applications where analytes are toxic in low concentrations or are only 
available in small quantities, with these situations occurring in a wide range of ar­
eas including health care, food safety and early-warning biological warfare agent 
detection.
The next stage of this work will involve the adaptation of the structured chips 
to provide complete discrimination of surface versus bulk fluorescence. This will 
necessitate the use of parabolic, as oppose to conical, structures. As a result, the 
associated systems, such as the patterning, excitation and detection systems, will 
require adaptation. The advantages of this discrimination are referred to above 
and include higher sensitivity and faster test times.
The evolution to polymer moulded microfluidic components will be a natural 
progression for this work and will facilitate the development of an ultimately 
portable immunosensor system. Also, due to the numerous advantages it displays 
over other polymers, including very low background fluorescence and excellent 
machinablility, Zeonor (Zeon Chemicals L.P., Louisville) will replace PMMA as 
the substrate polymer.
Further research will be carried out in the area of antibody to polymer im­
mobilisation strategies. A single-step immobilisation strategy using sol-gel-based 
tunable refractive index films will be researched, which will further simplify the 
system and increase its application flexibility. Antibody orientation techniques 
will be developed in order to significantly increase the antigen-binding capacity of 
the immunosensor. Possible strategies include biotinylation of carbohydrate on 
the Fc portion of the antibody or cleaving of antibody fragments and immobilising 
via the available thiol group.
Due to the fact that this is a relatively new area of research and that the need 
for diagnostics is increasing rapidly, it is predicted that immunosensor research 
will expand significantly during the next few years. Thus, both the completed 
work presented in this thesis and the future developments referred to, are relevant 
and timely and have the potential to have considerable impact in this area.
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